<SEC-DOCUMENT>0001140361-25-031186.txt : 20250814
<SEC-HEADER>0001140361-25-031186.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814152850
ACCESSION NUMBER:		0001140361-25-031186
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250812
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SPX Technologies, Inc.
		CENTRAL INDEX KEY:			0000088205
		STANDARD INDUSTRIAL CLASSIFICATION:	METALWORKING MACHINERY & EQUIPMENT [3540]
		ORGANIZATION NAME:           	06 Technology
		EIN:				381016240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-06948
		FILM NUMBER:		251218024

	BUSINESS ADDRESS:	
		STREET 1:		6325 ARDREY KELL ROAD
		STREET 2:		SUITE 400
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277
		BUSINESS PHONE:		980-474-3700

	MAIL ADDRESS:	
		STREET 1:		6325 ARDREY KELL ROAD
		STREET 2:		SUITE 400
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SPX CORP
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SEALED POWER CORP
		DATE OF NAME CHANGE:	19880515
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20052979x3_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:spxc="http://spx.com/20250812" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.7.1.5324
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_833ca6278d524b5992cbb3957dd215fb" contextRef="c20250812to20250812" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_20a1f1e0b0ff4784871a52432c5cec63" contextRef="c20250812to20250812">0000088205</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6a981d5b34f34ddc9500cc8d5f4a4023" contextRef="c20250812to20250812">NYSE</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="spxc-20250812.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250812to20250812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000088205</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-12</xbrli:startDate><xbrli:endDate>2025-08-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div style="text-align: center; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">UNITED STATES</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND
      EXCHANGE COMMISSION</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">Washington, D.C.
      20549</div>

    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; width: 25%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div><br/>
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_282092fe9e2a4a868bc2af5490ce424c" contextRef="c20250812to20250812">8-K</ix:nonNumeric></div>

    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; width: 25%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_e3e9090faae643a0aaa56edfd8e1ea75" contextRef="c20250812to20250812" format="ixt:date-monthname-day-year-en">August 12, 2025</ix:nonNumeric></div>

    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; width: 25%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div><br/>
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_d2e7220e9c9a47839816231bea7e3456" contextRef="c20250812to20250812">SPX TECHNOLOGIES, INC.</ix:nonNumeric><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter) </div>

    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; width: 25%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_9d150545495c415fb13fddcb30491cba" contextRef="c20250812to20250812" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_f1c82bac3ed240cebcfc4ecaec16a9d0" contextRef="c20250812to20250812">001-06948</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_5dcb4cd1a1af43048da3d2b8036eb214" contextRef="c20250812to20250812">88-3567996</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(State or other jurisdiction</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">of incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Commission</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">File Number)</div>
          </td>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(I.R.S. Employer</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Identification No.)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">&#160;</td>

    <td style="width: 34%; vertical-align: top;">&#160;</td>

    <td style="width: 33%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top;" colspan="2" rowspan="1">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_ee9ba791d9d54ca8844d2fc60f8e5a3c" contextRef="c20250812to20250812">6325 Ardrey Kell Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_d32488ebb92f41589b76a75e54dc8dd9" contextRef="c20250812to20250812">Suite 400</ix:nonNumeric>,</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_b240bfd8717b4f07bd8a289c0fa1319a" contextRef="c20250812to20250812">Charlotte</ix:nonNumeric>,
              <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_ded8fd4ad9cd4ad2b2469432ac6be95a" contextRef="c20250812to20250812" format="ixt-sec:stateprovnameen">North Carolina</ix:nonNumeric></div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Address of Principal Executive Officer)</div>
          </td>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_28e51f5699954e51bb51ef7d24a8ca95" contextRef="c20250812to20250812">28277</ix:nonNumeric><br/>
            </div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" id="Fact_725411ff89a24079a7c4c1cf716d6fdc" contextRef="c20250812to20250812">980</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_a4d399c20f1b4664bc908f9751afc8fa" contextRef="c20250812to20250812">474-3700</ix:nonNumeric></div>

    <div><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">N/A</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Former name or former address, if changed since last report)</div>

    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; width: 25%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
      any of the following provisions:</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: #000000; font-family: 'Segoe UI Symbol', 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_cf531161edea453090f2091dc21e4b83" contextRef="c20250812to20250812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: #000000; font-family: 'Segoe UI Symbol', 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_77b672ce78c8493898ab035299a96211" contextRef="c20250812to20250812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: #000000; font-family: 'Segoe UI Symbol', 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_0224889554bb4af79ec589a379aee524" contextRef="c20250812to20250812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: #000000; font-family: 'Segoe UI Symbol', 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_6469781dce564dd0802c2b5c0985f8f4" contextRef="c20250812to20250812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
    </div>

    <div><br/>
    </div>

    <div style="text-align: center;"><span style="font-weight: bold;">Securities registered pursuant to Section 12(b) of the Act:</span></div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 32.72%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Title of each class</div>
          </td>

    <td style="width: 20.52%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Trading Symbol(s)</div>
          </td>

    <td style="width: 46.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.72%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_0c0e70c5123647adbdba1c440b568346" contextRef="c20250812to20250812">Common Stock, par value $0.01</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 20.52%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_46297e4de46d499090d35daa2245d7f3" contextRef="c20250812to20250812">SPXC</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 46.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_6a981d5b34f34ddc9500cc8d5f4a4023">New York Stock Exchange</span><br/>
            </div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of
      this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div><br/>
    </div>

    <div style="text-align: right; margin-left: 72pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_cfa537401b6f4c4fb1d0dc20759bdef6" contextRef="c20250812to20250812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
      with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: 'Segoe UI Symbol', 'Segoe UI Symbol', sans-serif;">&#9744;</span></div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Item 8.01. </span>Other Events.</div>

    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On August 12, 2025, SPX Technologies, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with BofA
      Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;) in connection with the offering, issuance and sale by the Company of
      2,659,575 shares of the Company&#8217;s common stock, $0.01 par value per share (the &#8220;Common Stock&#8221;), at an offering price of $188.00 per share (the &#8220;Offering&#8221;). The Offering closed on August 14, 2025. In addition, the Company has granted the Underwriters
      a 30-day option to purchase up to an additional 398,936 shares of its Common Stock.</div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">The Offering was made pursuant to an effective shelf registration
        statement on Form S-3 (Registration No. 333-</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">289489) and a related prospectus supplement and accompanying prospectus filed with the Securities and
        Exchange Commission (the &#8220;SEC&#8221;).</span></div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The gross proceeds to the Company from the Offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by the
      Company, were approximately $500.0 million.</div>

    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Underwriting Agreement contains customary representations, warranties, covenants and agreements by the Company, customary conditions to
      closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and
      covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting
      parties.</div>

    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by reference to the full text of the
      Underwriting Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated by reference herein.</div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Latham &amp; Watkins LLP, counsel to the Company, has issued an opinion regarding the validity of the shares of Common Stock offered and sold in the
      Offering.&#160; A copy of the opinion is filed as Exhibit 5.1 to this Current Report on Form 8-K.</div>

    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01. Financial Statements and Exhibits.</div>

    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits.</div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 8.89%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit No.</div>
          </td>

    <td style="width: 0.6%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90.51%; vertical-align: bottom;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8.89%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20052979x3_ex1-1.htm">1.1</a></div>
          </td>

    <td style="width: 0.6%; vertical-align: middle;">&#160;</td>

    <td style="width: 90.51%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Underwriting Agreement, dated August 12, 2025, by and among the Company and <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">BofA Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC</span>, as representatives of the several underwriters named therein.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8.89%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20052979x3_ex5-1.htm">5.1</a></div>
          </td>

    <td style="width: 0.6%; vertical-align: middle;">&#160;</td>

    <td style="width: 90.51%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Opinion of Latham &amp; Watkins LLP.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8.89%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20052979x3_ex5-1.htm">23.1</a></div>
          </td>

    <td style="width: 0.6%; vertical-align: middle;">&#160;</td>

    <td style="width: 90.51%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Consent of Latham &amp; Watkins LLP (included in Exhibit 5.1).</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8.89%; vertical-align: middle;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
          </td>

    <td style="width: 0.6%; vertical-align: middle;">&#160;</td>

    <td style="width: 90.51%; vertical-align: bottom;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the inline XBRL document).</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div><br/>
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div><br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
      the undersigned hereunto duly authorized.</div>

    <div><br/>
    </div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;"> </span><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 50%; vertical-align: middle;">&#160;</td>

    <td style="vertical-align: top;" colspan="2">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SPX TECHNOLOGIES, INC.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle;">&#160;</td>

    <td style="vertical-align: middle;" colspan="2">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: August 14, 2025</div>
          </td>

    <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
          </td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/S/ MARK A. CARANO</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle;">&#160;</td>

    <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mark A. Carano</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle;">&#160;</td>

    <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Vice President, Chief Financial Officer and Treasurer</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  </div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ny20052979x3_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.7.1.5324
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="font-weight: normal; text-align: right;"><font style="font-weight: bold;">Exhibit 1.1</font><br>
  </div>
  <div style="font-weight: normal;"> <br>
  </div>
  <div style="font-weight: normal;">
    <div style="text-align: center;">SPX TECHNOLOGIES, INC.</div>
    <div>&#160;</div>
    <div style="text-align: center;">(a Delaware corporation)</div>
    <div>&#160;</div>
    <div style="text-align: center;">2,659,575 Shares of Common Stock</div>
    <div>&#160;</div>
    <div style="text-align: center;"><u>UNDERWRITING AGREEMENT</u></div>
    <div>&#160;</div>
    <div>Dated:&#160; August 12, 2025</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;">SPX TECHNOLOGIES, INC.</div>
    <div>&#160;</div>
    <div style="text-align: center;">(a Delaware corporation)</div>
    <div>&#160;</div>
    <div style="text-align: center;">2,659,575 Shares of Common Stock, par value $0.01 per share</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">&#160;UNDERWRITING AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: right;">August 12, 2025</div>
    <div style="text-indent: -58.5pt; margin-left: 58.5pt;">BofA Securities, Inc.</div>
    <div>One Bryant Park</div>
    <div>New York, New York&#160; 10036</div>
    <div>&#160;</div>
    <div style="text-indent: -58.5pt; margin-left: 58.5pt;">J.P. Morgan Securities LLC</div>
    <div>383 Madison Avenue</div>
    <div>New York, New York 10179</div>
    <div>&#160;</div>
    <div style="text-indent: -58.5pt; margin-left: 58.5pt;">Wells Fargo Securities, LLC</div>
    <div>500 West 33rd Street, 14th Floor</div>
    <div>New York, New York 10001</div>
    <div>&#160;</div>
    <div>as Representatives of the several Underwriters</div>
    <div>&#160;</div>
    <div>Ladies and Gentlemen:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SPX Technologies, Inc., a Delaware corporation (the &#8220;Company&#8221;), confirms its agreement with the Underwriters named in Schedule A hereto (collectively, the &#8220;Underwriters,&#8221; which term shall also
      include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom BofA Securities, Inc. (&#8220;BofA&#8221;), J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are acting as Representatives (in such capacity, the
      &#8220;Representatives&#8221;), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of Common Stock, par value $0.01 per share, of the Company (the &#8220;Common
      Stock&#8221;) set forth in Schedule A hereto and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 398,936 additional shares of Common Stock.&#160;
      The aforesaid 2,659,575 shares of Common Stock (the &#8220;Initial Securities&#8221;) to be purchased by the Underwriters and all or any part of the 398,936 shares of Common Stock subject to the option described in Section 2(b) hereof (the &#8220;Option Securities&#8221;)
      are herein called, collectively, the &#8220;Securities.&#8221;</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The Company understands that the Underwriters propose to make a public offering of the Securities as soon as the Representatives deem advisable after this underwriting agreement (this &#8220;Agreement&#8221;)
      has been executed and delivered.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; text-indent: 36pt;">The Company has prepared and filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) an automatic shelf registration statement on Form S-3 (File No. 333-289489) covering the public
      offering and sale of certain securities, including the Securities, under the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;), and the rules and regulations promulgated thereunder (the &#8220;1933 Act Regulations&#8221;), which automatic shelf registration
      statement became effective under Rule 462(e) under the 1933 Act Regulations (&#8220;Rule 462(e)&#8221;). Such registration statement, as of any time, means such registration statement as amended by any post-effective amendments thereto to such time, including
      the exhibits and any schedules thereto at such time, the documents incorporated or deemed to be incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act and the documents otherwise deemed to be a part thereof
      as of such time pursuant to Rule 430B under the 1933 Act Regulations (&#8220;Rule 430B&#8221;), is referred to herein as the &#8220;Registration Statement;&#8221; provided, however, that the &#8220;Registration Statement&#8221; without reference to a time means such registration
      statement as amended by any post-effective amendments thereto as of the time of the first contract of sale for the Securities, which time shall be considered the &#8220;new effective date&#8221; of such registration statement with respect to the Securities
      within the meaning of paragraph (f)(2) of Rule 430B, including the exhibits and schedules thereto as of such time, the documents incorporated or deemed incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act
      and the documents otherwise deemed to be a part thereof as of such time pursuant to the Rule 430B.&#160; Each preliminary prospectus used in connection with the offering of the Securities, including the documents incorporated or deemed to be incorporated
      by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act, are collectively referred to herein as a &#8220;preliminary prospectus.&#8221;&#160; Promptly after execution and delivery of this Agreement, the Company will prepare and file a final prospectus
      relating to the Securities in accordance with the provisions of Rule 424(b) under the 1933 Act Regulations (&#8220;Rule 424(b)&#8221;).&#160; The final prospectus, in the form first furnished or made available to the Underwriters for use in connection with the
      offering of the Securities, including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act, are collectively referred to herein as the &#8220;Prospectus.&#8221;&#160; For purposes of this
      Agreement, all references to the Registration Statement, any preliminary prospectus, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data
      Gathering, Analysis and Retrieval system (or any successor system)(&#8220;EDGAR&#8221;). </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">As used in this Agreement:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;Applicable Time&#8221; means 5:45 P.M., New York City time, on August 12, 2025 or such other time as agreed by the Company and BofA.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;General Disclosure Package&#8221; means any Issuer General Use Free Writing Prospectuses (as defined herein) issued at or prior to the Applicable Time, the most recent preliminary
      prospectus (including any documents incorporated therein by reference) that is distributed to investors prior to the Applicable Time and the information included on Schedule B-1 hereto, all considered together.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;Issuer Free Writing Prospectus&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 of the 1933 Act Regulations (&#8220;Rule 433&#8221;), including without limitation any &#8220;free
      writing prospectus&#8221; (as defined in Rule 405 of the 1933 Act Regulations (&#8220;Rule 405&#8221;)) relating to the Securities that is (i) required to be filed with the Commission by the Company, (ii) a &#8220;road show that is a written communication&#8221; within the
      meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Securities or of the offering that does not
      reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;Issuer General Use Free Writing Prospectus&#8221; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors (other than a &#8220;<font style="font-style: italic;">bona fide</font> electronic road show,&#8221; as defined in Rule 433), as evidenced by its being specified in Schedule B-2 hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;Issuer Limited Use Free Writing Prospectus&#8221; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">All references in this Agreement to financial statements and schedules and other information which is &#8220;contained,&#8221; &#8220;included&#8221; or &#8220;stated&#8221; (or other references of like import) in the Registration
      Statement, any preliminary prospectus or the Prospectus shall be deemed to include all such financial statements and schedules and other information incorporated or deemed incorporated by reference in the Registration Statement, any preliminary
      prospectus or the Prospectus, as the case may be, prior to the execution and delivery of this Agreement; and all references in this Agreement to amendments or supplements to the Registration Statement, any preliminary prospectus or the Prospectus
      shall be deemed to include the filing of any document under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (collectively, the &#8220;1934 Act&#8221;), incorporated or deemed to be incorporated by reference
      in the Registration Statement, such preliminary prospectus or the Prospectus, as the case may be, at or after the execution and delivery of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 1.&#160;&#160;&#160;&#160;&#160;&#160; Representations and Warranties.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Representations and Warranties by the Company</font>.&#160; The Company represents and warrants to each Underwriter as of the date hereof, the Applicable
      Time, the Closing Time (as defined below) and any Date of Delivery (as defined below), and agrees with each Underwriter, as follows:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: #000000;"><u>Registration Statement</u></font><a name="z_DV_M91"></a><font style="color: #000000;"><u> and Prospectuses</u></font>.&#160; The Company
      meets the requirements for use of Form S-3 under the 1933 Act.&#160; The Registration Statement is an &#8220;automatic shelf registration statement&#8221; (as defined in Rule 405) and the Securities have been and remain eligible for registration by the Company on
      such automatic shelf registration statement.&#160; The Registration Statement has become effective under the 1933 Act.&#160; No stop order suspending the effectiveness of the Registration Statement has been issued under the 1933 Act, no order preventing or
      suspending the use of any preliminary prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company&#8217;s knowledge, contemplated.&#160; The Company has complied with each
      request (if any) from the Commission for additional information.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">Each of the Registration Statement and any post-effective amendment thereto, at the time of its effectiveness, each deemed effective date with respect to the Underwriters pursuant
      to Rule 430B(f)(2) under the 1933 Act Regulations, the Applicable Time, the Closing Time and any Date of Delivery complied and will comply in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations.&#160; Each preliminary
      prospectus, the Prospectus and any amendment or supplement thereto, at the time each was filed with the Commission, and, in each case, at the Applicable Time, the Closing Time and any Date of Delivery complied and will comply in all material respects
      with the requirements of the 1933 Act Regulations and each preliminary prospectus and the Prospectus delivered to the Underwriters for use in connection with this offering was identical to the electronically transmitted copies thereof filed with the
      Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, when they became effective or at the time they were or
      hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the 1934 Act and the rules and regulations of the Commission under the 1934 Act (the &#8220;1934 Act Regulations&#8221;).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Accurate Disclosure</u>.&#160; Neither the Registration Statement nor any amendment thereto, at its effective time, on the date hereof, at the Closing Time or at any
      Date of Delivery, contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.&#160; At the
      Applicable Time and any Date of Delivery, neither (A) the General Disclosure Package nor (B) any individual Issuer Limited Use Free Writing Prospectus, when considered together with the General Disclosure Package, included, includes or will include
      an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160; Neither the Prospectus
      nor any amendment or supplement thereto, as of its issue date, at the time of any filing with the Commission pursuant to Rule 424(b), at the Closing Time or at any Date of Delivery, included, includes or will include an untrue statement of a material
      fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160; The documents incorporated or deemed to be incorporated by
      reference in the Registration Statement, the General Disclosure Package and the Prospectus, at the time the Registration Statement became effective or when such documents incorporated by reference were filed with the Commission, as the case may be,
      when read together with the other information in the Registration Statement, the General Disclosure Package or the Prospectus, as the case may be, did not and will not include an untrue statement of a material fact or omit to state a material fact
      required to be stated therein or necessary to make the statements therein not misleading.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">The representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement (or any amendment thereto), the General
      Disclosure Package or the Prospectus (or any amendment or supplement thereto) made in reliance upon and in conformity with written information furnished to the Company by any Underwriter through BofA expressly for use therein.&#160; For purposes of this
      Agreement, the only information so furnished shall be the information in the first paragraph under the heading &#8220;Underwriting&#8211;Commissions and Discounts,&#8221; the information in the second, third and fourth paragraphs under the heading &#8220;Underwriting&#8211;Price
      Stabilization, Short Positions and Penalty Bids&#8221; and the information under the heading &#8220;Underwriting&#8211;Electronic Offer, Sale and Distribution of Shares&#8221; in each case contained in the Prospectus (collectively, the &#8220;Underwriter Information&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; <u>Issuer Free Writing Prospectuses</u>.&#160; No Issuer Free Writing Prospectus conflicts or will conflict with the information contained in the Registration Statement or
      the Prospectus, including any document incorporated by reference therein, and any preliminary or other prospectus deemed to be a part thereof that has not been superseded or modified.&#160;&#160; Any offer that is a written communication relating to the
      Securities made prior to the initial filing of the Registration Statement by the Company or any person acting on its behalf (within the meaning, for this paragraph only, of Rule 163(c) of the 1933 Act Regulations) has been filed with the Commission
      in accordance with the exemption provided by Rule 163 under the 1933 Act Regulations (&#8220;Rule 163&#8221;) and otherwise complied with the requirements of Rule 163, including without limitation the legending requirement, to qualify such offer for the
      exemption from Section 5(c) of the 1933 Act provided by Rule 163.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Well-Known Seasoned Issuer.</u>&#160; (A) At the original effectiveness of the Registration Statement, (B) at the time of the most recent amendment thereto for the
      purposes of complying with Section 10(a)(3) of the 1933 Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the 1934 Act or form of prospectus), (C) at the time the Company or any
      person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the 1933 Act) made any offer relating to the&#160; Securities in reliance on the exemption of Rule 163 under the 1933 Act, and (D) as of the Applicable Time, the
      Company was and is a &#8220;well-known seasoned issuer&#8221; (as defined in Rule 405).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Company Not Ineligible Issuer</u>.&#160; At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that
      the Company or another offering participant made a <font style="font-style: italic;">bona fide</font> offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations) of the Securities and at the date hereof, the Company was not and is not
      an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160;&#160; <u>Independent Accountants</u>.&#160; The accountants who certified the financial statements and supporting schedules included in the Registration Statement, the General
      Disclosure Package and the Prospectus are independent public accountants as required by the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations and the Public Company Accounting Oversight Board.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(vii)&#160;&#160;&#160;&#160;&#160; <u>Financial Statements; Non-GAAP Financial Measures</u>.&#160; The financial statements included or incorporated by reference in the Registration Statement, the General
      Disclosure Package and the Prospectus, together with the related schedules and notes, present fairly, in all material respects, the financial position of the Company and its consolidated subsidiaries at the dates indicated and the statement of
      operations, stockholders&#8217; equity and cash flows of the Company and its consolidated subsidiaries for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) applied
      on a consistent basis throughout the periods involved.&#160; The supporting schedules, if any, present fairly, in all material respects, in accordance with GAAP the information required to be stated therein.&#160; The selected financial data and the summary
      financial information included in the Registration Statement, the General Disclosure Package and the Prospectus present fairly in all material respects the information shown therein and have been compiled on a basis consistent with that of the
      audited financial statements included therein.&#160; Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the General
      Disclosure Package or the Prospectus under the 1933 Act or the 1933 Act Regulations.&#160; All disclosures contained in the Registration Statement, the General Disclosure Package or the Prospectus, or incorporated by reference therein, regarding &#8220;non-GAAP
      financial measures&#8221; (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the 1934 Act and Item 10 of Regulation S-K of the 1933 Act, to the extent applicable. The interactive
      data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in
      accordance with the Commission's rules and guidelines applicable thereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(viii)&#160;&#160;&#160;&#160; <u>No Material Adverse Change in Business</u>.&#160; Except as otherwise stated therein, since the respective dates as of which information is given in the Registration
      Statement, the General Disclosure Package or the Prospectus, (A) there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries
      considered as one enterprise, whether or not arising in the ordinary course of business (a &#8220;Material Adverse Effect&#8221;), (B) there have been no transactions entered into by the Company or any of its subsidiaries, other than those in the ordinary course
      of business, which are material with respect to the Company and its subsidiaries considered as one enterprise, and (C) there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Good Standing of the Company</u>.&#160; The Company has been duly organized and is validly existing as a corporation in good standing under the laws of the State of
      Delaware and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus and to enter into and perform its
      obligations under this Agreement; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or
      leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Good Standing of Subsidiaries</u>.&#160; Each &#8220;significant subsidiary&#8221; of the Company (as such term is defined in Rule 1-02 of Regulation S-X) (each, a &#8220;Subsidiary&#8221; and,
      collectively, the &#8220;Subsidiaries&#8221;) has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its incorporation or organization, has corporate or similar power and authority to own, lease and operate its
      properties and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification
      is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify or to be in good standing would not, singly or in the aggregate, reasonably be expected to result in a Material
      Adverse Effect.&#160; Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, all of the issued and outstanding capital stock of each Subsidiary has been duly authorized and validly issued, is fully
      paid and non&#8209;assessable and is owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity.&#160; None of the outstanding shares of capital stock of any Subsidiary
      were issued in violation of the preemptive or similar rights of any securityholder of such Subsidiary.&#160; The only subsidiaries of the Company are the subsidiaries listed on Exhibit 21 to the Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xi)&#160;&#160;&#160;&#160;&#160;&#160; <u>Capitalization</u>.&#160; The authorized, issued and outstanding shares of capital stock of the Company are as set forth or incorporated by reference in the Registration
      Statement, the General Disclosure Package and the Prospectus (except for subsequent issuances, if any, pursuant to this Agreement, pursuant to reservations, agreements or employee benefit or equity incentive plans referred to in the Registration
      Statement, the General Disclosure Package and the Prospectus or pursuant to the conversion, exercise or vesting and settlement of convertible securities, options or restricted stock units referred to in the Registration Statement, the General
      Disclosure Package and the Prospectus).&#160; The outstanding shares of capital stock of the Company have been duly authorized and validly issued and are fully paid and non&#8209;assessable.&#160; None of the outstanding shares of capital stock of the Company were
      issued in violation of the preemptive or other similar rights of any securityholder of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xii)&#160;&#160;&#160;&#160;&#160;&#160; <u>Authorization of Agreement</u>.&#160; This Agreement has been duly authorized, executed and delivered by the Company.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xiii)&#160;&#160;&#160;&#160; <u>Authorization and Description of Securities</u>.&#160; The Securities to be purchased by the Underwriters from the Company have been duly authorized for issuance and sale
      to the Underwriters pursuant to this Agreement and, when issued and delivered by the Company pursuant to this Agreement against payment of the consideration set forth herein, will be validly issued and fully paid and non&#8209;assessable; and the issuance
      of the Securities is not subject to the preemptive or other similar rights of any securityholder of the Company, except as have been duly and validly waived.&#160; The Common Stock conforms in all material respects to all statements relating thereto
      contained in the Registration Statement, the General Disclosure Package and the Prospectus and such description conforms in all material respects to the rights set forth in the instruments defining the same.&#160; No holder of Securities will be subject
      to personal liability solely by reason of being such a holder.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xiv)&#160;&#160;&#160;&#160; <u>Registration Rights</u>.&#160; There are no persons with registration rights or other similar rights to have any securities registered for sale pursuant to the
      Registration Statement or otherwise registered for sale or sold by the Company under the 1933 Act pursuant to this Agreement, other than those rights that have been duly and validly waived.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xv)&#160;&#160;&#160;&#160;&#160; <u>Absence of Violations, Defaults and Conflicts</u>.&#160; Neither the Company nor any of its subsidiaries is (A) in violation of its charter, by-laws or similar
      organizational document, (B) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or
      instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound or to which any of the properties or assets of the Company or any subsidiary is subject (collectively, &#8220;Agreements and Instruments&#8221;),
      except for such defaults that would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect, or (C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court,
      governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Company or any of its subsidiaries or any of their respective properties, assets or operations (each, a &#8220;Governmental Entity&#8221;),
      except for such violations that would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect.&#160; The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
      herein and in the Registration Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as described therein under the caption &#8220;Use of
      Proceeds&#8221;) and compliance by the Company with its obligations hereunder have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or
      constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or any subsidiary pursuant to, the Agreements and
      Instruments (except for such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect), nor will such action result
      in any violation of the (i) provisions of the charter, by-laws or similar organizational document of the Company or any of its subsidiaries or (ii) any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity except,
      in the case of clause (ii) above, for such violation that would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect.&#160; As used herein, a &#8220;Repayment Event&#8221; means any event or condition which gives the holder
      of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#8217;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xvi)&#160;&#160;&#160;&#160; <u>Absence of Labor Dispute</u>.&#160; No labor dispute with the employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is imminent,
      which would reasonably be expected to result in a Material Adverse Effect.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xvii)&#160; &#160; <u>Absence of Proceedings</u>.&#160; Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, there is no action, suit,
      proceeding, inquiry or investigation before or brought by any Governmental Entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries, which would, singly or in the aggregate,
      reasonably be expected to result in a Material Adverse Effect, or which would, singly or in the aggregate, reasonably be expected to materially and adversely affect their respective properties or assets or the consummation of the transactions
      contemplated in this Agreement or the performance by the Company of its obligations hereunder; and the aggregate of all pending legal or governmental proceedings to which the Company or any such subsidiary is a party or of which any of their
      respective properties or assets is the subject which are not described in the Registration Statement, the General Disclosure Package and the Prospectus, including ordinary routine litigation incidental to the business, would not, singly or in the
      aggregate, reasonably be expected to result in a Material Adverse Effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xviii)&#160;&#160;&#160; <u>Accuracy of Exhibits</u>.&#160; There are no contracts or documents which are required to be described in the Registration Statement, the General Disclosure Package or
      the Prospectus or to be filed as exhibits to the Registration Statement which have not been so described and filed as required.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xix)&#160;&#160;&#160;&#160;&#160; <u>Absence of Further Requirements</u>.&#160; No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Governmental
      Entity is necessary or required for the performance by the Company of its obligations hereunder, in connection with the offering, issuance or sale of the Securities hereunder or the consummation of the transactions contemplated by this Agreement,
      except such as have been already obtained or as may be required under the 1933 Act, the 1933 Act Regulations, the rules of the New York Stock Exchange, state securities laws or the rules of Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xx)&#160;&#160;&#160;&#160;&#160;&#160; <u>Possession of Licenses and Permits</u>.&#160; The Company and its subsidiaries possess such permits, licenses, approvals, consents and other authorizations (collectively,
      &#8220;Governmental Licenses&#8221;) issued by the appropriate Governmental Entities necessary to conduct the business now operated by them, except where the failure so to possess would not, singly or in the aggregate, reasonably be expected to result in a
      Material Adverse Effect.&#160; The Company and its subsidiaries are in compliance with the terms and conditions of all Governmental Licenses, except where the failure so to comply would not, singly or in the aggregate, reasonably be expected to result in
      a Material Adverse Effect.&#160; All of the Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not,
      singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect.&#160; Neither the Company nor any of its subsidiaries has received any written notice of proceedings from any Governmental Entity relating to the revocation or
      modification of any Governmental Licenses, which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to result in a Material Adverse Effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxi)&#160;&#160;&#160;&#160; <u>Title to Property</u>.&#160; The Company and its subsidiaries have good and marketable title to all real property owned by them and good title to all other properties
      owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind except such as (A) are described in the Registration Statement, the General Disclosure Package and the
      Prospectus or (B) do not, singly or in the aggregate, materially and adversely affect the value of such property and do not adversely interfere with the use made and proposed to be made of such property by the Company or any of its subsidiaries; and
      all of the leases and subleases material to the business of the Company and its subsidiaries, considered as one enterprise, and under which the Company or any of its subsidiaries holds properties described in the Registration Statement, the General
      Disclosure Package or the Prospectus, are in full force and effect, and neither the Company nor any such subsidiary has any notice of any material claim of any sort that has been asserted by anyone adverse to the rights of the Company or any
      subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such subsidiary to the continued possession of the leased or subleased premises under any such lease or sublease.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxii)&#160;&#160;&#160; <u>Possession of Intellectual Property</u>.&#160; Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus or would not, singly or
      in the aggregate, result in a Material Adverse Effect, (A) the Company and its subsidiaries own or possess, or can acquire on reasonable terms, adequate patents, copyrights, know&#8209;how (including trade secrets and other unpatented and/or unpatentable
      proprietary or confidential information, systems or procedures), trademarks, service marks, trade names or other intellectual property rights (collectively, &#8220;Intellectual Property&#8221;) necessary to carry on the business as now operated by them and (B)
      neither the Company nor any of its subsidiaries has, in the last three (3) years, received any written notice or is otherwise aware of any infringement or violation of Intellectual Property owned by others or any facts or circumstances which would
      reasonably be expected to render any Intellectual Property owned the Company or any of its subsidiaries invalid or inadequate to protect the interest of the Company or any of its subsidiaries therein.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxiii)&#160;&#160;&#160; <u>Environmental Laws</u>.&#160; Except as described in the Registration Statement, the General Disclosure Package and the Prospectus or would not, singly or in the
      aggregate, reasonably be expected to result in a Material Adverse Effect, (A) neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of
      common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of worker health (to the extent relating to exposure to Hazardous
      Materials (as defined below)), the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or
      threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, &#8220;Hazardous Materials&#8221;) or to the manufacture, processing,
      distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &#8220;Environmental Laws&#8221;), (B) the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable
      Environmental Laws and are each in compliance with their requirements, (C) there are no pending or, to the knowledge of the Company, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of
      noncompliance or violation, investigations or proceedings relating to any Environmental Law against the Company or any of its subsidiaries and (D) the Company is not aware of any events or circumstances that would reasonably be expected to form the
      basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or Governmental Entity, against or affecting the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxiv)&#160;&#160;&#160; <u>Accounting Controls and Disclosure Controls</u>.&#160; The Company and each of its subsidiaries, taken as a whole, maintain <a name="z_DV_C475"></a>effective internal
      control over financial reporting (as defined under Rule 13&#8209;a15 and 15d&#8209;15 under the 1934 Act Regulations) and a system of internal accounting controls designed to provide reasonable assurances that (A) transactions are executed in accordance with
      management&#8217;s general or specific authorization; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (C) access to assets is permitted only in
      accordance with management&#8217;s general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (E) the
      interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared
      in accordance with the Commission's rules and guidelines applicable thereto.&#160; Since the end of the Company&#8217;s most recent audited fiscal year, there has been (1) no material weakness in the Company&#8217;s internal control over financial reporting (whether
      or not remediated) and (2) no change in the Company&#8217;s internal control over financial reporting that has materially and adversely affected, or is reasonably likely to materially and adversely affect, the Company&#8217;s internal control over financial
      reporting. The Company and each of its subsidiaries <a name="z_DV_C484"></a>maintain an effective system of<a name="z_DV_M280"></a> disclosure controls and procedures<a name="z_DV_C485"></a> (as defined in Rule 13a&#8209;15 and Rule 15d&#8209;15 under the 1934
      Act Regulations) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the
      Commission&#8217;s rules and forms, and is accumulated and communicated to the Company&#8217;s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding
      disclosure.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxv)&#160;&#160; &#160; <u></u><u>Compliance with the Sarbanes-Oxley Act.</u>&#160; There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in
      their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906
      related to certifications.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxvi)&#160;&#160;&#160; <u></u><u>Payment of Taxes</u>.&#160; Except, in each case, as the failure to do so would not, singly or in the aggregate, reasonably be expected to result in a Material
      Adverse Effect or as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus, (i) the Company and its subsidiaries have filed all tax returns that are required to have been filed by them pursuant to applicable law
      and (ii) have paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been
      established by the Company. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined are adequate to meet any assessments or re-assessments for
      additional income tax for any years not finally determined, except to the extent of any inadequacy that would not result in a Material Adverse Effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxvii)&#160; <u>Insurance</u>.&#160; The Company and its subsidiaries carry or are entitled to the benefits of insurance, with financially sound and reputable insurers, in such amounts and
      covering such risks as is generally maintained by similarly sized companies of established repute engaged in the same or similar business, and all such insurance is in full force and effect.&#160; The Company has no reason to believe that it or any of its
      subsidiaries will not be able (A) to renew its existing insurance coverage as and when such policies expire or (B) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and
      at a cost that would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect.&#160; Neither of the Company nor any of its subsidiaries has been denied any insurance coverage which it has sought or for which it has
      applied.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxviii) <u>Investment Company Act</u>.&#160; The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and the application of the net
      proceeds therefrom as described in the Registration Statement, the General Disclosure Package and the Prospectus will not be required, to register as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxix)&#160;&#160; <u>Absence of Manipulation</u>.&#160; Neither the Company nor, to the knowledge of the Company, any affiliate of the Company has taken, nor will the Company or any affiliate
      take, directly or indirectly, any action which is designed, or would reasonably be expected, to cause or result in, or which constitutes, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale
      of the Securities or to result in a violation of Regulation M under the 1934 Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxx)&#160;&#160;&#160; <font style="font-style: italic;"><u>No Unlawful Payments</u></font>.&#160; None of the Company, any of its subsidiaries or, any director, officer or, to the knowledge of the
      Company, any agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political
      activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled
      entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of
      any provision of the Foreign Corrupt Practices Act of 1977 (the &#8220;FCPA&#8221;), as amended or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or
      committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption laws, including, without limitation, making use of the mails or any means or instrumentality of interstate commerce
      corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such term is
      defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or
      other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to
      maintain and enforce, policies and procedures reasonably designed to promote and ensure, and which are reasonably expected to continue to promote and ensure, continued compliance therewith and with all applicable anti-bribery and anti-corruption
      laws.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxxi)&#160;&#160; <u>Money Laundering Laws</u>.&#160; The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial
      recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules,
      regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#8220;Money Laundering Laws&#8221;); and no action, suit or proceeding by or before any Governmental Entity involving the Company or any of its
      subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxxii)&#160; <u>No Conflicts with Sanctions Laws</u>.&#160; Neither the Company nor any of its subsidiaries, nor any of their respective directors or officers, nor to the knowledge of the
      Company, any agent, employee, affiliate or other person associated with or acting on behalf&#160; of the Company or any of its subsidiaries is, or is acting on behalf of one or more individuals or entities that are, currently the subject or the target of
      any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;OFAC&#8221;) or the U.S. Department of State or the Bureau of Industry and the
      Security of the U.S. Department of Commerce, and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council (&#8220;UNSC&#8221;), the European Union, His Majesty&#8217;s Treasury of the
      United Kingdom (&#8220;HMT&#8221;), or other relevant sanctions authority (collectively, &#8220;Sanctions&#8221;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is, or which government is, the subject or target
      of Sanctions, including, without limitation, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic, the Crimea Region of Ukraine, the non-government-controlled areas of Kherson and Zaporizhzhia of Ukraine, Cuba, Iran and
      North Korea (each, a &#8220;Sanctioned Country&#8221;); and the Company will not directly or indirectly use the proceeds of the offering of the Securities or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or
      other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of the funding or facilitation, is the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business in any
      Sanctioned Country or (iii) in any other manner that would result in a violation by any person (including any person participating in the offering of the Securities, whether as underwriter, agent, advisor, investor or otherwise) of Sanctions. Since
      April 24, 2019, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction was or is the subject or the target of
      Sanctions or with any Sanctioned Country in violation of Sanctions.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxxiii)&#160; <u>Lending Relationship</u><font style="font-style: italic;">.&#160; </font>Except as disclosed in the Registration Statement, the General Disclosure Package and the
      Prospectus, the Company (i) does not have any material lending or other relationship with any bank or lending affiliate of any Underwriter and (ii) does not intend to use any of the proceeds from the sale of the Securities to repay any outstanding
      debt owed to any affiliate of any Underwriter.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxxiv)&#160; <u></u><u>Statistical and Market-Related Data</u>.&#160; Any statistical and market-related data included in the Registration Statement, the General Disclosure Package or the
      Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate in all material respects and, to the extent required, the Company has obtained the written consent to the use of such
      data from such sources.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxxv)&#160;&#160; <u>Cybersecurity</u>.&#160; Except as described in the Registration Statement, the General Disclosure Package and the Prospectus or would not, singly or in the aggregate,
      result in a Material Adverse Effect: (A) there has been no security breach or incident, unauthorized access or disclosure, or other compromise of or relating to the Company or its subsidiaries information technology and computer systems, networks,
      hardware, software, data and databases (including the data and information of their respective customers, employees, suppliers, vendors and any third party data maintained, processed or stored by the Company and its subsidiaries, and any such data
      processed or stored by third parties on behalf of the Company and its subsidiaries), equipment or technology (collectively, &#8220;<u>IT Systems and Data</u>&#8221;), (B) neither the Company nor its subsidiaries have been notified of, and each of them have no
      knowledge of any event or condition that could result in, any security breach or incident, unauthorized access or disclosure or other compromise to their IT Systems and Data,&#160; (C) the Company&#160; and its subsidiaries have implemented commercially
      reasonable controls, policies, procedures, and technological safeguards designed to maintain and protect the integrity, continuous operation, redundancy and security of their IT Systems and Data reasonably consistent with industry standards and
      practices, or as required by applicable law and (D) the Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or
      regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xxxvi) <font style="font-style: italic;">No Ratings</font>.&#160; Neither the Company nor its subsidiaries have any debt securities or preferred stock that are rated by any
      &#8220;nationally recognized statistical rating organization&#8221; (as defined in Section 3(a)(62) of the 1934 Act).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><a name="z_DV_M278"></a>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Officer&#8217;s Certificates.&#160; </font>Any certificate signed by any officer of the Company or any of its subsidiaries delivered to
      the Representatives or to counsel for the Underwriters shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered thereby.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 2.&#160;&#160;&#160;&#160;&#160;&#160; <u>Sale and Delivery to Underwriters; Closing</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Initial Securities</font>.&#160; On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set
      forth, the Company agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not jointly, agrees to purchase from the Company, at the price per share set forth in Schedule A, that number of Initial Securities
      set forth in Schedule A opposite the name of such Underwriter, plus any additional number of Initial Securities which such Underwriter may become obligated to purchase pursuant to the provisions of Section 10 hereof,&#160; subject, in each case, to such
      adjustments among the Underwriters as BofA in its sole discretion shall make to eliminate any sales or purchases of fractional shares.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Option Securities</font>.&#160; In addition, on the basis of the representations and warranties herein contained and subject to the terms and conditions
      herein set forth, the Company hereby grants an option to the Underwriters, severally and not jointly, to purchase up to an additional 398,936 shares of Common Stock, at the price per share set forth in Schedule A, less an amount per share equal to
      any dividends or distributions declared by the Company and payable on the Initial Securities but not payable on the Option Securities.&#160; The option hereby granted may be exercised for 30 days after the date hereof and may be exercised in whole or in
      part at any time from time to time upon notice by the Representatives to the Company setting forth the number of Option Securities as to which the several Underwriters are then exercising the option and the time and date of payment and delivery for
      such Option Securities.&#160; Any such time and date of delivery (a &#8220;Date of Delivery&#8221;) shall be determined by the Representatives, but shall not be later than seven full business days after the exercise of said option, nor in any event prior to the
      Closing Time.&#160; If the option is exercised as to all or any portion of the Option Securities, each of the Underwriters, acting severally and not jointly, will purchase that proportion of the total number of Option Securities then being purchased which
      the number of Initial Securities set forth in Schedule A opposite the name of such Underwriter bears to the total number of Initial Securities, subject, in each case, to such adjustments as BofA in its sole discretion shall make to eliminate any
      sales or purchases of fractional shares.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Payment</font>.&#160; Payment of the purchase price for, and delivery of certificates or security entitlements for, the Initial Securities shall be made at
      the offices of Davis Polk &amp; Wardwell LLP, 450 Lexington Avenue, New York, NY 10017, or at such other place as shall be agreed upon by the Representatives and the Company, at 9:00 A.M. (New York City time) on the first (second, if the pricing
      occurs after 4:30 P.M. (New York City time) on any given day) business day after the date hereof (unless postponed in accordance with the provisions of Section 10), or such other time not later than ten business days after such date as shall be
      agreed upon by the Representatives and the Company (such time and date of payment and delivery being herein called &#8220;Closing Time&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">In addition, in the event that any or all of the Option Securities are purchased by the Underwriters, payment of the purchase price for, and delivery of certificates or security entitlements for,
      such Option Securities shall be made at the above&#8209;mentioned offices, or at such other place as shall be agreed upon by the Representatives and the Company, on each Date of Delivery as specified in the notice from BofA to the Company.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Payment shall be made to the Company by wire transfer of immediately available funds to a bank account designated by the Company against delivery to the Representatives for the respective accounts of
      the Underwriters of certificates or security entitlements for the Securities to be purchased by them.&#160; It is understood that each Underwriter has authorized the Representatives, for its account, to accept delivery of, receipt for, and make payment of
      the purchase price for, the Initial Securities and the Option Securities, if any, which it has agreed to purchase.&#160; BofA, individually and not as representative of the Underwriters, may (but shall not be obligated to) make payment of the purchase
      price for the Initial Securities or the Option Securities, if any, to be purchased by any Underwriter whose funds have not been received by the Closing Time or the relevant Date of Delivery, as the case may be, but such payment shall not relieve such
      Underwriter from its obligations hereunder.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Covenants of the Company</u>.&#160; The Company&#160; covenants with each Underwriter as follows:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Compliance with Securities Regulations and Commission Requests</font>.&#160; The Company, subject to Section 3(b), will comply with the requirements of Rule
      430B, and will notify the Representatives promptly, and confirm the notice in writing (which may be via email), (i) when any post-effective amendment to the Registration Statement shall become effective or any amendment or supplement to the
      Prospectus shall have been filed, (ii) of the receipt of any comments from the Commission, (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus, including any document
      incorporated by reference therein or for additional information, (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order preventing or
      suspending the use of any preliminary prospectus or the Prospectus, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes
      or of any examination pursuant to Section 8(d) or 8(e) of the 1933 Act concerning the Registration Statement and (v) if the Company becomes the subject of a proceeding under Section 8A of the 1933 Act in connection with the offering of the
      Securities.&#160; The Company will effect all filings required under Rule 424(b), in the manner and within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and will take such steps as it deems necessary to ascertain promptly
      whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such prospectus.&#160; The Company will use commercially reasonable efforts to
      prevent the issuance of any stop order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof as soon as practicable.&#160; The Company shall pay the required Commission filing fees relating to the Securities within the
      time required by Rule 456(b)(1)(i) under the 1933 Act Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the 1933 Act Regulations (including, if applicable, by updating the &#8220;Calculation of
      Registration Fee&#8221; table in accordance with Rule 456(b)(1)(ii) either in a post-effective amendment to the Registration Statement or on the cover page of a prospectus filed pursuant to Rule 424(b)).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Continued Compliance with Securities Laws</font>.&#160; The Company will comply with the 1933 Act, the 1933 Act Regulations, the 1934 Act and the 1934 Act
      Regulations so as to permit the completion of the distribution of the Securities as contemplated in this Agreement and in the Registration Statement, the General Disclosure Package and the Prospectus.&#160; If at any time when a prospectus relating to the
      Securities is (or, but for the exception afforded by Rule 172 of the 1933 Act Regulations (&#8220;Rule 172&#8221;), would be) required by the 1933 Act to be delivered in connection with sales of the Securities, any event shall occur or condition shall exist as a
      result of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i) amend the Registration Statement in order that the Registration Statement will not include an untrue statement of a material fact or omit to
      state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) amend or supplement the General Disclosure Package or the Prospectus in order that the General Disclosure Package or the Prospectus,
      as the case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered to a
      purchaser or (iii) amend the Registration Statement or amend or supplement the General Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements of the 1933 Act or the 1933 Act Regulations, the Company will
      promptly (A) give the Representatives notice of such event, (B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement, the General Disclosure Package or the Prospectus
      comply with such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish the Representatives with copies of any such amendment or supplement and (C) file with the Commission any such amendment or supplement;
      provided that the Company shall not file or use any such amendment or supplement to which the Representatives or counsel for the Underwriters shall reasonably object.&#160; The Company will furnish to the Underwriters such number of copies of such
      amendment or supplement as the Underwriters may reasonably request.&#160; The Company has given the Representatives notice of any filings made pursuant to the 1934 Act or 1934 Act Regulations within 48 hours prior to the Applicable Time; the Company will
      give the Representatives notice of its intention to make any such filing from the Applicable Time to the Closing Time and will furnish the Representatives with copies of any such documents a reasonable amount of time prior to such proposed filing, as
      the case may be, and will not file or use any such document to which the Representatives or counsel for the Underwriters shall reasonably object.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Delivery of Registration Statements</font>.&#160; The Company has furnished or will deliver to the Representatives and counsel for the Underwriters, without
      charge, conformed copies of the Registration Statement as originally filed and each amendment thereto (including exhibits filed therewith or incorporated by reference therein and documents incorporated or deemed to be incorporated by reference
      therein) and conformed copies of all consents and certificates of experts, and will also deliver to the Representatives, without charge, a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits)
      for each of the Underwriters.&#160; The copies of the Registration Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to
      the extent permitted by Regulation S&#8209;T.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Delivery of Prospectuses</font>.&#160; The Company has delivered to each Underwriter, without charge, as many copies of each preliminary prospectus as such
      Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted by the 1933 Act.&#160; The Company will furnish to each Underwriter, without charge, during the period when a prospectus relating to the
      Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered under the 1933 Act, such number of copies of the Prospectus (as amended or supplemented) as such Underwriter may reasonably request.&#160; The Prospectus and
      any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S&#8209;T.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Blue Sky Qualifications</font>.&#160; The Company will use its reasonable best efforts, in cooperation with the Underwriters, to qualify the Securities for
      offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Representatives may reasonably designate and to maintain such qualifications in effect so long as required to complete the
      distribution of the Securities; provided, however, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so
      qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Rule 158</font>.&#160; The Company will timely file (which filing may be satisfied via EDGAR) such reports pursuant to the 1934 Act as are necessary in order
      to make generally available to its securityholders as soon as practicable an earnings statement for the purposes of, and to provide to the Underwriters the benefits contemplated by, the last paragraph of Section 11(a) of the 1933 Act.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Use of Proceeds</font>.&#160; The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in the Registration
      Statement, the General Disclosure Package and the Prospectus under &#8220;Use of Proceeds.&#8221;</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Listing</font>.&#160; The Company will use its reasonable best efforts to effect and maintain the listing of the Securities on the New York Stock Exchange.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Restriction on Sale of Securities</font>.&#160; During a period of 60 days from the date of the Prospectus (the &#8220;Restricted Period&#8221;), the Company will not,
      without the prior written consent of the Representatives, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to
      purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or publicly file any registration statement under the 1933 Act with respect to any of the
      foregoing, (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Stock, whether any such swap or transaction described in
      clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise, or (iii) publicly disclose the intention to do any of the foregoing described in clauses (i) and (ii) above.&#160; The foregoing sentence
      shall not apply to (A) the Securities to be sold hereunder, (B) any shares of Common Stock issued by the Company upon the exercise of an option or warrant, the vesting or settlement of restricted stock, restricted stock units, or other equity-based
      awards or the conversion of a security outstanding on the date hereof and referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (C) any shares of Common Stock issued, or options to purchase Common Stock,
      restricted stock, restricted stock units or other equity-based awards granted pursuant to existing employee benefit plans of the Company referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (D) the
      establishment or amendment of a trading plan on behalf of a shareholder, officer or director of the Company pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Common Stock, provided that (i) such plan does not provide for
      the transfer of Common Stock during the Restricted Period and (ii) to the extent a public announcement or filing under the Exchange Act, if any, is required of the Company regarding the establishment of such plan, such announcement or filing shall
      include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period, (E) any shares of Common Stock issued pursuant to any non-employee director stock plan or dividend reinvestment plan referred
      to in the Registration Statement, the General Disclosure Package and the Prospectus or (F) filing by the Company of a registration statement with the Commission on Form S-8 in respect of any shares or other equity instruments issued pursuant to any
      plans or programs described in (C) or (E) above, (G) the confidential submission by the Company of any registration statement with the Commission in respect of any shares of Common Stock, provided that (i) no public filing with the Commission or any
      other public announcement may be made during the Restricted Period in relation <font style="color: #000000;">to such registration</font>, (ii) the Representatives must have received prior written notice from the Company of a confidential submission
      of a registration statement with the Commission during the Restricted Period at least five (5) business days prior to such submission and (iii) no securities of the Company may be sold, distributed or exchanged during the Restricted Period, or (H)
      the sale or the issuance of shares of Common Stock or any securities convertible into, or exercisable or exchangeable for, shares of Common Stock, or the entrance into an agreement to issue Common Stock or any securities convertible into, or
      exercisable or exchangeable for, shares of Common Stock, in connection with any merger, joint venture, strategic alliances, commercial or other collaborative transaction or the acquisition or license of the business, property, technology or other
      assets of another individual or entity or the assumption of an employee benefit plan in connection with a merger or acquisition, <font style="font-style: italic;">provided</font> that the aggregate number of shares of Common Stock or any securities
      convertible into, or exercisable or exchangeable for, Common Stock that the Company may issue or agree to issue pursuant to this clause (H) shall not exceed 10% of the total number of shares of Common Stock issued and outstanding immediately
      following completion of the transactions contemplated by this Agreement; and provided further that the recipients thereof provide to the Representatives a signed lock-up letter substantially in the form of the lock-up letter described in Section
      5(h).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Reporting Requirements</font>.&#160; The Company, during the period when a Prospectus relating to the Securities is (or, but for the exception afforded by
      Rule 172, would be) required to be delivered under the 1933 Act, will file all documents required to be filed with the Commission pursuant to the 1934 Act within the time periods required by the 1934 Act and 1934 Act Regulations.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Issuer Free Writing Prospectuses</font>.&#160; The Company agrees that, unless it obtains the prior written consent of the Representatives, it will not make
      any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#8220;free writing prospectus,&#8221; or a portion thereof, required to be filed by the Company with the Commission or retained by
      the Company under Rule 433; provided that the Representatives will be deemed to have consented to the Issuer Free Writing Prospectuses listed on Schedule B-2 hereto and any &#8220;road show that is a written communication&#8221; within the meaning of Rule
      433(d)(8)(i) that has been reviewed by the Representatives.&#160; The Company represents that it has treated or agrees that it will treat each such free writing prospectus consented to, or deemed consented to, by the Representatives as an &#8220;issuer free
      writing prospectus,&#8221; as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including timely filing with the Commission where required, legending and record keeping.&#160; If at
      any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration
      Statement, any preliminary prospectus or the Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the
      circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict,
      untrue statement or omission.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 4.&#160;&#160;&#160;&#160;&#160;&#160; <u>Payment of Expenses</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Expenses</font>. The Company will pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including
      (i) the preparation, printing and filing of the Registration Statement (including financial statements and exhibits) as originally filed and each amendment thereto, (ii) the preparation, printing and delivery to the Underwriters of copies of each
      preliminary prospectus, each Issuer Free Writing Prospectus and the Prospectus and any amendments or supplements thereto and any costs associated with electronic delivery of any of the foregoing by the Underwriters to investors, (iii) the
      preparation, issuance and delivery of the certificates or security entitlements for the Securities to the Underwriters, including any stock or other transfer taxes and any stamp or similar duties payable upon the sale, issuance or delivery of the
      Securities to the Underwriters, (iv) the fees and disbursements of the Company&#8217;s counsel, accountants and other advisors, (v) the qualification of the Securities under securities laws in accordance with the provisions of Section 3(e) hereof,
      including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection therewith and in connection with the preparation of the Blue Sky Survey and any supplement thereto, (vi) the fees and expenses of any
      transfer agent or registrar for the Securities, (vii) the costs and expenses of the Company relating to investor presentations on any &#8220;road show&#8221; undertaken in connection with the marketing of the Securities, including without limitation, expenses
      associated with the production of road show slides and graphics, fees and expenses of any consultants engaged by the Company in connection with the road show presentations, travel and lodging expenses of the representatives and officers of the
      Company and any such consultants, and 50% of the cost of aircraft and other transportation chartered in connection with the road show, (viii) the filing fees incident to, and the reasonable fees and disbursements of counsel to the Underwriters in
      connection with, the review by FINRA of the terms of the sale of the Securities (provided that, the amount payable by the Company with respect to the fees and disbursements of counsel for the Underwriters incurred pursuant to this clause (viii) and
      clause (v) above shall not exceed $30,000 in the aggregate), (ix) the fees and expenses incurred in connection with the listing of the Securities on the New York Stock Exchange and (x) the costs and expenses (including, without limitation, any
      damages or other amounts payable in connection with legal or contractual liability) associated with the reforming of any contracts for sale of the Securities made by the Underwriters caused by a breach of the representation contained in the third
      sentence of Section 1(a)(ii).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination of Agreement</font>.&#160; If this Agreement is terminated by the Representatives in accordance with the provisions of Section 5, Section 9(a)(i)
      or (iii) or Section 10 hereof, the Company shall reimburse the non-defaulting Underwriters for all of their reasonably incurred and documented out&#8209;of&#8209;pocket expenses, including the reasonable and documented fees and disbursements of counsel for the
      Underwriters; provided that, if this Agreement is terminated by the Representatives pursuant to Section 10 hereof, the Company will have no obligation to reimburse any defaulting Underwriter.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 5.&#160;&#160;&#160;&#160;&#160;&#160; <u>Conditions of Underwriters&#8217; Obligations</u>.&#160; The obligations of the several Underwriters hereunder are subject to the accuracy of the representations and warranties of the
      Company contained herein or in certificates of any officer of the Company or any of its subsidiaries delivered pursuant to the provisions hereof, to the performance by the Company of its covenants and other obligations hereunder, and to the following
      further conditions:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Effectiveness of Registration Statement</font>.&#160; The Registration Statement has become effective and, at the Closing Time, no stop order suspending the
      effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under the 1933 Act, no order preventing or suspending the use of any preliminary prospectus or the Prospectus has been issued and no proceedings for
      any of those purposes have been instituted or are pending or, to the Company&#8217;s knowledge, contemplated; and the Company has complied with each request (if any) from the Commission for additional information.&#160; The Company shall have paid the required
      Commission filing fees relating to the Securities within the time period required by Rule 456(b)(1)(i) under the 1933 Act Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the 1933 Act
      Regulations and, if applicable, shall have updated the &#8220;Calculation of Registration Fee&#8221; table in accordance with Rule 456(b)(1)(ii) either in a post-effective amendment to the Registration Statement or on the cover page of a prospectus filed
      pursuant to Rule 424(b).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-style: italic;">Opinion and Negative Assurance Letter of Counsel for Company</font>.&#160; At the Closing Time, the Representatives shall have received an opinion and a
      negative assurance letter, each dated the Closing Time, of Latham &amp; Watkins LLP, counsel for the Company, in each case in form and substance satisfactory to the Representatives.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Opinion and Negative Assurance Letter of Counsel for Underwriters</font>.&#160; At the Closing Time, the Representatives shall have received an opinion and a
      negative assurance letter, dated the Closing Time, of Davis Polk &amp; Wardwell LLP, counsel for the Underwriters, in each case in form and substance satisfactory to the Representatives.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Officer&#8217;s Certificate</font>.&#160; At the Closing Time, there shall not have been, since the date hereof or since the respective dates as of which
      information is given in the Registration Statement, the General Disclosure Package or the Prospectus, any Material Adverse Effect, and the Representatives shall have received a certificate of the Chief Executive Officer, President or Chief Financial
      Officer of the Company, dated the Closing Time, to the effect that (i) there has been no such Material Adverse Effect, (ii) the representations and warranties of the Company in this Agreement are true and correct with the same force and effect as
      though expressly made at and as of the Closing Time, (iii) the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied at or prior to the Closing Time, and (iv) no stop order suspending the
      effectiveness of the Registration Statement under the 1933 Act has been issued, no order preventing or suspending the use of any preliminary prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been
      instituted or are pending or, to their knowledge, contemplated.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Accountant&#8217;s Comfort Letter</font>.&#160; At the time of the execution of this Agreement, the Representatives shall have received from Deloitte &amp; Touche
      LLP a letter, dated such date, in form and substance satisfactory to the Representatives, together with signed or reproduced copies of such letter for each of the other Underwriters containing statements and information of the type ordinarily
      included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained in the Registration Statement, the General Disclosure Package and the Prospectus.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Bring-down Comfort Letter</font>.&#160; At the Closing Time, the Representatives shall have received from Deloitte &amp; Touche LLP a letter, dated as of the
      Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (e) of this Section, except that the specified date referred to shall be a date not more than three business days prior to the Closing
      Time.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Approval of Listing</font>.&#160; At the Closing Time, the Securities shall have been approved for listing on the New York Stock Exchange, subject only to
      official notice of issuance.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Lock-up Agreements</font>.&#160; At the date of this Agreement, the Representatives shall have received an agreement substantially in the form of Exhibit A
      hereto signed by the persons listed on Schedule C hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Conditions to Purchase of Option Securities</font>.&#160; In the event that the Underwriters exercise their option provided in Section 2(b) hereof to
      purchase all or any portion of the Option Securities, the representations and warranties of the Company contained herein and the statements in any certificates furnished by the Company and any of its subsidiaries hereunder shall be true and correct
      as of each Date of Delivery and, at the relevant Date of Delivery, the Representatives shall have received:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Officer&#8217;s Certificate</u>.&#160; A certificate, dated such Date of Delivery, of the Chief Executive Officer, President or Chief Financial Officer of the Company
      confirming that the certificate delivered at the Closing Time pursuant to Section 5(d) hereof remains true and correct as of such Date of Delivery.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Opinion and Negative Assurance Letter of Counsel for Company</u>.&#160; If requested by the Representatives, an opinion and a negative assurance letter of Latham
      &amp; Watkins LLP, counsel for the Company, in form and substance satisfactory to counsel for the Underwriters, dated such Date of Delivery, relating to the Option Securities to be purchased on such Date of Delivery and otherwise to the same effect
      as the opinion and negative assurance letter required by Section 5(b) hereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160; <u>Opinion and Negative Assurance Letter of Counsel for Underwriters</u>.&#160; If requested by the Representatives, an opinion and a negative assurance letter of Davis Polk
      &amp; Wardwell LLP, counsel for the Underwriters, dated such Date of Delivery, relating to the Option Securities to be purchased on such Date of Delivery and otherwise to the same effect as the opinion required by Section 5(c) hereof.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160; <u>Bring-down Comfort Letter</u>.&#160; If requested by the Representatives, a letter from Deloitte &amp; Touche LLP, in form and substance satisfactory to the
      Representatives and dated such Date of Delivery, substantially in the same form and substance as the letter furnished to the Representatives pursuant to Section 5(e) hereof, except that the &#8220;specified date&#8221; in the letter furnished pursuant to this
      paragraph shall be a date not more than three business days prior to such Date of Delivery.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Additional Documents</font>.&#160; At the Closing Time and at each Date of Delivery (if any) counsel for the Underwriters shall have been furnished with such
      customary documents and opinions as they may reasonably require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to evidence the accuracy of any of the representations or
      warranties, or the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities as herein contemplated shall be satisfactory in form and substance to the
      Representatives and counsel for the Underwriters.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination of Agreement</font>.&#160; If any condition specified in this Section shall not have been fulfilled when and as required to be fulfilled, this
      Agreement, or, in the case of any condition to the purchase of Option Securities on a Date of Delivery which is after the Closing Time, the obligations of the several Underwriters to purchase the relevant Option Securities, may be terminated by the
      Representatives by notice to the Company at any time at or prior to Closing Time or such Date of Delivery, as the case may be, and such&#160; termination shall be without liability of any party to any other party except as provided in Section 4 and except
      that Sections 1, 6, 7, 8, 14, 15, 16 and 17 shall survive any such termination and remain in full force and effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 6.&#160;&#160;&#160;&#160;&#160;&#160; <u>Indemnification</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Indemnification of Underwriters</font>.&#160; The Company agrees to indemnify and hold harmless each Underwriter, its affiliates (as such term is defined in
      Rule 501(b) under the 1933 Act (each, an &#8220;Affiliate&#8221;)), its selling agents and each person, if any, who controls any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act as follows:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160; against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged untrue statement of a material
      fact contained in the Registration Statement (or any amendment thereto), including any information deemed to be a part thereof pursuant to Rule 430B, or the omission or alleged omission therefrom of a material fact required to be stated therein or
      necessary to make the statements therein not misleading or arising out of any untrue statement or alleged untrue statement of a material fact included (A) in any preliminary prospectus, any Issuer Free Writing Prospectus,&#160; the General Disclosure
      Package or the Prospectus (or any amendment or supplement thereto) or (B) in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities (&#8220;Marketing
      Materials&#8221;), including any roadshow or investor presentations made to investors by the Company (whether in person or electronically), or the omission or alleged omission in any preliminary prospectus, Issuer Free Writing Prospectus, Prospectus or in
      any Marketing Materials of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160; &#160; against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or
      any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to
      Section 6(d) below) any such settlement is effected with the written consent of the Company;</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160; against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel chosen by BofA), reasonably incurred in investigating, preparing or
      defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or
      omission, to the extent that any such expense is not paid under (i) or (ii) above;</div>
    <div>&#160;</div>
    <div style="text-align: justify;">provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission
      made in the Registration Statement (or any amendment thereto), including any information deemed to be a part thereof pursuant to Rule 430B, the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) in reliance upon and
      in conformity with the Underwriter Information.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Indemnification of Company, Directors and Officers</font>.&#160; Each Underwriter severally agrees to indemnify and hold harmless the Company, its directors,
      each of its officers who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act against any and all loss, liability, claim, damage and
      expense described in the indemnity contained in subsection (a) of this Section, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendment
      thereto), including any information deemed to be a part thereof pursuant to Rule 430B, the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Underwriter Information.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Actions against Parties; Notification</font>.&#160; Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying party of
      any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced
      as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement.&#160; In the case of parties indemnified pursuant to Section 6(a) above, counsel to the indemnified
      parties shall be selected by BofA, and, in the case of parties indemnified pursuant to Section 6(b) above, counsel to the indemnified parties shall be selected by the Company.&#160; An indemnifying party may participate at its own expense in the defense
      of any such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party.&#160; In no event shall the indemnifying parties be liable for fees and
      expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the
      same general allegations or circumstances.&#160; No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation
      or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 6 or Section 7 hereof (whether or not the indemnified parties
      are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii)
      does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Settlement without Consent if Failure to Reimburse</font>.&#160; If at any time an indemnified party shall have requested an indemnifying party to reimburse
      the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 6(a)(ii) effected without its written consent if (i) such settlement is entered
      into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii)
      such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 7.&#160;&#160;&#160;&#160; <u>Contribution</u>.&#160; If the indemnification provided for in Section 6 hereof is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any
      losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i)
      in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Securities pursuant to this Agreement or (ii) if the allocation provided
      by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and of the Underwriters, on
      the other hand, in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, in connection with the offering of the Securities pursuant to this Agreement shall be deemed
      to be in the same respective proportions as the total net proceeds from the offering of the Securities pursuant to this Agreement (before deducting expenses) received by the Company, on the one hand, and the total underwriting discount received by
      the Underwriters, on the other hand, in each case as set forth on the cover of the Prospectus, bear to the aggregate initial public offering price of the Securities as set forth on the cover of the Prospectus.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The relative fault of the Company, on the one hand, and the Underwriters, on the other hand, shall be determined by reference to, among other things, whether any such untrue or alleged untrue
      statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct
      or prevent such statement or omission.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined by pro rata allocation (even if the Underwriters were treated
      as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 7.&#160; The aggregate amount of losses, liabilities, claims, damages and expenses
      reasonably incurred by an indemnified party and referred to above in this Section 7 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation,
      or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Notwithstanding the provisions of this Section 7, <font style="color: #000000;">no Underwriter shall be required to contribute any amount in excess of the underwriting commissions received by such
        Underwriter in connection with the Securities underwritten by it and distributed to the public</font>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
      misrepresentation.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">For purposes of this Section 7, each person, if any, who controls an Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act and each Underwriter&#8217;s Affiliates and
      selling agents shall have the same rights to contribution as such Underwriter, and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning
      of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Company.&#160; The Underwriters&#8217; respective obligations to contribute pursuant to this Section 7 are several in proportion to the number of
      Initial Securities set forth opposite their respective names in Schedule A hereto and not joint.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 8.&#160;&#160;&#160;&#160; <u>Representations, Warranties and Agreements to Survive</u>.&#160; All representations, warranties and agreements contained in this Agreement or in certificates of officers of the Company
      or any of its subsidiaries submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any
      Underwriter, its officers or directors, any person controlling the Company and (ii) delivery of and payment for the Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 9.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination of Agreement</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination</font>.&#160; The Representatives may terminate this Agreement, by notice to the Company, at any time at or prior to the Closing Time (i) if
      there has been, in the judgment of the Representatives, since the time of execution of this Agreement or since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, any
      Material Adverse Effect, or (ii) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or
      any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Representatives, impracticable or
      inadvisable to <font style="color: #000000;">proceed with the completion of the offering</font> or to enforce contracts for the sale of the Securities, or (iii) if trading in any securities of the Company has been suspended or materially limited by
      the Commission or the New York Stock Exchange, or (iv) if trading generally on the NYSE MKT or the New York Stock Exchange or in the Nasdaq Global Select Market has been suspended or materially limited, or minimum or maximum prices for trading have
      been fixed, or maximum ranges for prices have been required, by any of said exchanges or by order of the Commission, FINRA or any other governmental authority, or (v) a material disruption has occurred in commercial banking or securities settlement
      or clearance services in the United States or with respect to Clearstream or Euroclear systems in Europe, or (vi) if a banking moratorium has been declared by either Federal or New York authorities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Liabilities</font>.&#160; If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to any other
      party except as provided in Section 4 hereof, and provided further that Sections 1, 6, 7, 8, 14, 15, 16 and 17 shall survive such termination and remain in full force and effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 10.&#160;&#160;&#160; <u>Default by One or More of the Underwriters</u>.&#160; If one or more of the Underwriters shall fail at the Closing Time or a Date of Delivery to purchase the Securities which it or they
      are obligated to purchase under this Agreement (the &#8220;Defaulted Securities&#8221;), the Representatives shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non&#8209;defaulting Underwriters, or any other underwriters
      reasonably acceptable to the Company, to purchase all, but not less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representatives shall not have completed such
      arrangements within such 24&#8209;hour period, then:</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">23</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the number of Defaulted Securities does not exceed 10% of the number of Securities to be purchased by the Underwriters on such date, each of the non&#8209;defaulting
      Underwriters shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions that their respective underwriting obligations hereunder bear to the underwriting obligations of all non&#8209;defaulting Underwriters, or</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; if the number of Defaulted Securities exceeds 10% of the number of Securities to be purchased by the Underwriters on such date, this Agreement or, with respect to any
      Date of Delivery which occurs after the Closing Time, the obligation of the Underwriters to purchase, and the Company to sell, the Option Securities to be purchased and sold on such Date of Delivery shall terminate without liability on the part of
      any non&#8209;defaulting Underwriter.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">No action taken pursuant to this Section shall relieve any defaulting Underwriter from liability in respect of its default.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">In the event of any such default which does not result in a termination of this Agreement or, in the case of a Date of Delivery which is after the Closing Time, which does not result in a termination
      of the obligation of the Underwriters to purchase and the Company to sell the relevant Option Securities, as the case may be, either the (i) Representatives or (ii) the Company shall have the right to postpone Closing Time or the relevant Date of
      Delivery, as the case may be, for a period not exceeding seven days in order to effect any required changes in the Registration Statement, the General Disclosure Package or the Prospectus or in any other documents or arrangements.&#160; As used herein,
      the term &#8220;Underwriter&#8221; includes any person substituted for an Underwriter under this Section 10.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 11.&#160;&#160;&#160; <u>Notices</u>.&#160; All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of
      telecommunication.&#160; Notices to the Underwriters shall be directed to BofA at One Bryant Park, New York, New York 10036, attention of Syndicate Department (email: dg.ecm_execution_services@bofa.com), with a copy to ECM Legal (email:
      dg.ecm_legal@bofa.com); to J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 , (fax: (212) 622-8358), Attention Equity Syndicate Desk and to Wells Fargo Securities, LLC, 500 West 33rd Street, New York, New York 10001,
      Attention: Equity Syndicate Department (fax no: (212) 214-5918)&#160; notices to the Company shall be directed to it at 6325 Ardrey Kell Road, Suite 400, Charlotte, North Carolina 28277, attention of the Chief Legal Officer.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 12.&#160;&#160;&#160;&#160; <u>No Advisory or Fiduciary Relationship</u>.&#160; The Company acknowledges and agrees that (a) the purchase and sale of the Securities pursuant to this Agreement, including the
      determination of the initial public offering price of the Securities and any related discounts and commissions, is an arm&#8217;s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, and does
      not constitute a recommendation, investment advice, or solicitation of any action by the Underwriters, (b) in connection with the offering of the Securities and the process leading thereto, each Underwriter is and has been acting solely as a
      principal and is not the agent or fiduciary of the Company, any of its subsidiaries, or its respective stockholders, creditors, employees or any other party, (c) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in
      favor of the Company with respect to the offering of the Securities or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company or any of its subsidiaries on other matters) and no
      Underwriter has any obligation to the Company with respect to the offering of the Securities except the obligations expressly set forth in this Agreement, (d) the Underwriters and their respective affiliates may be engaged in a broad range of
      transactions that involve interests that differ from those of the Company, and (e) the Underwriters have not provided any legal, accounting, regulatory, investment or tax advice with respect to the offering of the Securities and the Company has
      consulted its own respective legal, accounting, financial, regulatory and tax advisors to the extent it deemed appropriate, and (f) none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a
      recommendation, investment advice or solicitation of any action by the Underwriters with respect to any entity or natural person.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">24</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 13.&#160;&#160;&#160;&#160; <u>Recognition of the U.S. Special Resolution Regimes</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and
      any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the
      laws of the United States or a state of the United States.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights
      under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of
      the United States or a state of the United States.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">For purposes of this Section 13, a &#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). &#8220;Covered Entity&#8221; means any of the following:
      (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii) a &#8220;covered FSI&#8221; as that
      term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#8220;U.S. Special
      Resolution Regime&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 14.&#160;&#160; <u>Parties</u>.&#160; This Agreement shall each inure to the benefit of and be binding upon the Underwriters, the Company and their respective successors.&#160; Nothing expressed or mentioned in
      this Agreement is intended or shall be construed to give any person, firm or corporation, other than the Underwriters, the Company and their respective successors and the controlling persons and officers and directors referred to in Sections 6 and 7
      and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained.&#160; This Agreement and all conditions and provisions hereof are intended to be for the sole
      and exclusive benefit of the Underwriters, the Company and their respective successors, and said controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no other person, firm or corporation.&#160;
      No purchaser of Securities from any Underwriter shall be deemed to be a successor by reason merely of such purchase.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 15.&#160;&#160;&#160; <u>Trial by Jury</u>.&#160; The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each of the Underwriters hereby
      irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 16.&#160;&#160;&#160; <u>GOVERNING LAW</u>.&#160; THIS AGREEMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS
      OF, THE STATE OF NEW YORK WITHOUT REGARD TO ITS CHOICE OF LAW PROVISIONS.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">25</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 17.&#160;&#160; &#160; <u>Consent to Jurisdiction; Waiver of Immunity</u>. Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby (&#8220;Related
      Proceedings&#8221;) shall be instituted in (i) the federal courts of the United States of America located in the City and County of New York, Borough of Manhattan or (ii) the courts of the State of New York located in the City and County of New York,
      Borough of Manhattan (collectively, the &#8220;Specified Courts&#8221;), and each party irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court (a &#8220;Related Judgment&#8221;), as
      to which such jurisdiction is non-exclusive) of such courts in any such suit, action or proceeding.&#160; Service of any process, summons, notice or document by mail to such party&#8217;s address set forth above shall be effective service of process for any
      suit, action or other proceeding brought in any such court.&#160; The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally
      waive and agree not to plead or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 18.&#160;&#160;&#160;&#160; <u>TIME</u>. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 19.&#160;&#160;&#160;&#160; <u>Counterparts and Electronic Signatures</u>.&#160; This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such
      counterparts shall together constitute one and the same Agreement. Electronic signatures complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. &#167;&#167; 301-309), as amended from time to time, or other applicable law will be
      deemed original signatures for purposes of this Agreement.&#160; Transmission by telecopy, electronic mail or other transmission method of an executed counterpart of this Agreement will constitute due and sufficient delivery of such counterpart.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">SECTION 20.&#160;&#160;&#160;&#160; <u>Effect of Headings</u>.&#160; The Section headings herein are for convenience only and shall not affect the construction hereof.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">26</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will
      become a binding agreement among the Underwriters and the Company in accordance with its terms.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z465ae9901d664c6c8bcb4843ddcc7f3d">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>Very truly yours,</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>SPX TECHNOLOGIES, INC.</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div><a name="z_Hlk205927755"></a>By:</div>
          </td>
          <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Mark A. Carano</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="margin-left: 9pt;">Title: Vice President, Chief Financial</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="margin-left: 9pt;">Officer and Treasurer</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">27</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>CONFIRMED AND ACCEPTED,</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">as of the date first above written:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1da37afba48a43e09919c597e9a4f8bb">

        <tr>
          <td colspan="2" style="vertical-align: top;">
            <div>BOFA SECURITIES, INC.</div>
          </td>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" style="vertical-align: top;">&#160;</td>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Fabrizio Wittenburg</div>
          </td>
          <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 15%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div>Authorized Signatory</div>
          </td>
          <td style="width: 55%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>For itself and as Representative of the other Underwriters named in Schedule A hereto.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">28</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb3904ccb0f6945b48351d216492b7f2b">

        <tr>
          <td colspan="2" style="vertical-align: top;">
            <div>J.P. MORGAN SECURITIES LLC</div>
          </td>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 60%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Arun Kumarathas</div>
          </td>
          <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 15%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div>Authorized Signatory</div>
          </td>
          <td style="width: 55%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>For itself and as Representative of the other Underwriters named in Schedule A hereto.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">29</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc0b4891b981a44e1a2f964b737240ae5">

        <tr>
          <td colspan="2" style="vertical-align: top;">
            <div>WELLS FARGO SECURITIES, LLC</div>
          </td>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" style="vertical-align: top;">&#160;</td>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>By:</div>
          </td>
          <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Christie MacDonald</div>
          </td>
          <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div>Managing Director</div>
          </td>
          <td style="width: 60%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>For itself and as Representative of the other Underwriters named in Schedule A hereto.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">30</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%Sch A - %%-->
    <div style="text-align: center;">SCHEDULE A</div>
    <div>&#160;</div>
    <div>The initial public offering price per share for the Securities shall be $188.00.</div>
    <div>&#160;</div>
    <div>The purchase price per share for the Securities to be paid by the several Underwriters shall be $180.48, being an amount equal to the initial public offering price set forth above less $7.5200 per share, subject to adjustment in accordance with
      Section 2(b) for dividends or distributions declared by the Company and payable on the Initial Securities but not payable on the Option Securities.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf22bb412c37846c79b70077b6486d6d2">

        <tr>
          <td style="width: 80%; vertical-align: bottom;">
            <div><a name="z_Hlk205545686"></a>Name of Underwriter</div>
          </td>
          <td style="width: 20%; vertical-align: bottom;">
            <div style="text-align: center;">Number of</div>
            <div style="text-align: center;"><u>Initial Securities</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">&#160;</td>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -58.5pt; margin-left: 58.5pt;">BofA Securities, Inc.</div>
          </td>
          <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">633,208</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div style="text-indent: -58.5pt; margin-left: 58.5pt;">J.P. Morgan Securities LLC</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">564,380</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Wells Fargo Securities, LLC</div>
          </td>
          <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">564,380</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div>TD Securities (USA) LLC</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">187,001</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Truist Securities, Inc.</div>
          </td>
          <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">187,001</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div>Citizens JMP Securities, LLC</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">99,734</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Fifth Third Securities, Inc.</div>
          </td>
          <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">99,734</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div><a name="z_Hlk205897790"></a>PNC Capital Markets LLC</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">99,734</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Oppenheimer &amp; Co. Inc.</div>
          </td>
          <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">49,867</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div><a name="z_Hlk205897795"></a>Scotia Capital (USA) Inc.</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">49,867</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a name="z_Hlk205897803"></a>William Blair &amp; Company, L.L.C.</div>
          </td>
          <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">49,867</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div>B. Riley Securities, Inc.</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">24,934</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Seaport Global Securities LLC</div>
          </td>
          <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">24,934</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top;">
            <div>WR Securities, LLC</div>
          </td>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">24,934</div>
          </td>
        </tr>
        <tr>
          <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="font-weight: bold; margin-left: 9pt;">Total</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div>
              <div style="text-align: center; font-weight: bold;">2,659,575</div>
            </div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="left" style="height: 2px; width: 30%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto; border: none;">
      <div> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">Sch A - 1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%UCA%2%Sch %%-->
    <div style="text-align: center;">SCHEDULE B-1</div>
    <div>&#160;</div>
    <div style="text-align: center;"><u>Pricing Terms</u></div>
    <div>&#160;</div>
    <div style="text-align: justify;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company is selling 2,659,575 shares of Common Stock.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company has granted an option to the Underwriters, severally and not jointly, to purchase up to an additional 398,936 shares of Common Stock.</div>
    <div>&#160;</div>
    <div>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The initial public offering price per share for the Securities shall be $188.00.</div>
    <div>&#160;</div>
    <div style="text-align: center;">SCHEDULE B-2</div>
    <div>&#160;</div>
    <div style="text-align: center;"><u>Free Writing Prospectuses</u></div>
    <div>&#160;</div>
    <div>None.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">Sch B</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%Sch C - %%-->
    <div style="text-align: center;">SCHEDULE C</div>
    <div>&#160;</div>
    <div style="text-align: center;"><u>List of Persons and Entities Subject to Lock-up</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z316f07708e404714b0dbec0e45b9ad70">

        <tr>
          <td style="width: 18pt;">&#160;</td>
          <td style="width: 27pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Patrick J. O&#8217;Leary</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z988d2a61a3cd49798bee0decd67408b6">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Ricky D. Puckett</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf5a181eb4cf4492e887951c7dc1a0bc2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>David A. Roberts</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z94a3c069c9bd42beb86275400c49205a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Meenal A. Sethna</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11da3a0ed4f147ba96706aeab99d697b">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Ruth G. Shaw</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zabc7c30d3c5847a4b08420091bba9fad">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Robert B. Toth</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z684323fb831541e793c0438b661c0819">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Tana L. Utley</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z366e80ce5e5a4f1386c565af8bc0eb6e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Angel Shelton Willis</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb6f60495b3e3407293100b2fb01e218c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">9.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Eugene J. Lowe, III</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z64ef714029834f7b83b984a4ae62927c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">10.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Mark A. Carano</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf637d1c3c8124113bda715bf2953dc6f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">11.</td>
          <td style="width: auto; vertical-align: top;">
            <div>J. Randall Data</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za58c8c332d0e4b9a8091040aa0412d84">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">12.</td>
          <td style="width: auto; vertical-align: top;">
            <div>John W. Swann, III</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8f6f02e7ff214cc59297cc6c303a1fcb">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">13.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Sean McClenaghan</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z206acc03db904d6bb23a971e21cec284">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">14.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Cher&#233;e H. Johnson</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za4d090e8af8840089ea0ba495b00a889">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">15.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Wayne M. McLaren</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb295c44466ba4419b10ca8d95508f13d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">16.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Jennifer Carpenter</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">Sch C - 1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%A-%%-->
    <div style="font-weight: bold;">[Form of lock-up from directors, officers or other stockholders pursuant to Section 5(h)]</div>
    <div>&#160;</div>
    <div style="text-align: right;">Exhibit A</div>
    <div>&#160;</div>
    <div style="text-indent: -58.5pt; margin-left: 58.5pt;">BofA Securities, Inc.</div>
    <div>One Bryant Park</div>
    <div>New York, New York&#160; 10036</div>
    <div>&#160;</div>
    <div style="text-indent: -58.5pt; margin-left: 58.5pt;">J.P. Morgan Securities LLC</div>
    <div>383 Madison Avenue</div>
    <div>New York, New York 10179</div>
    <div>&#160;</div>
    <div style="text-indent: -58.5pt; margin-left: 58.5pt;">Wells Fargo Securities, LLC</div>
    <div>500 West 33rd Street, 14th Floor</div>
    <div>New York, New York 10001</div>
    <div>&#160;</div>
    <div>as Representatives of the several</div>
    <div>&#160;&#160;Underwriters to be named in the</div>
    <div>&#160;&#160;within&#8209;mentioned Underwriting Agreement</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z03c0a477484149b3b71aa84a55a07808" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

          <tr style="vertical-align: top;">
            <td style="width: 36pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;">Re:</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><u>Proposed Public Offering of Common Stock by SPX Technologies, Inc.</u></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>Dear Ladies and Gentlemen:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The undersigned, a securityholder and/or an officer and/or a director, as applicable, of SPX Technologies, Inc., a Delaware corporation (the &#8220;Company&#8221;), understands that BofA Securities, Inc., J.P.
      Morgan Securities LLC and Wells Fargo Securities, LLC (the &#8220;Representatives&#8221;) propose to enter into an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with the Company providing for the public offering (the &#8220;Public Offering&#8221;) of shares of the
      Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;).&#160; In recognition of the benefit that the Public Offering will confer upon the undersigned as a securityholder and/or an officer and/or a director, as applicable, of the Company,
      and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with each underwriter to be named in the Underwriting Agreement that, during the period beginning on the date hereof
      and ending on the date that is 60 days from the date of the Underwriting Agreement (the &#8220;Lock-Up Period&#8221;), the undersigned will not, without the prior written consent of the Representatives (i) directly or indirectly, offer, pledge, sell, contract to
      sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of any shares of the Company&#8217;s Common Stock or any securities convertible
      into or exercisable or exchangeable for Common Stock, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition (including, without limitation, Common Stock
      or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) and securities which may be issued upon exercise
      of a stock option or warrant) (collectively, the &#8220;Lock-Up Securities&#8221;), or exercise any right with respect to the registration of any of the Lock-Up Securities, or file, cause to be filed or cause to be confidentially submitted any registration
      statement in connection therewith, under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) (ii) enter into any hedging, swap, loan or any other agreement or any transaction (including, without limitation, any short sale or the purchase or
      sale of, or entry into, any put or call option, or combination thereof, forward or any other derivative transaction or instrument, however described or defined) that transfers, in whole or in part, directly or indirectly, the economic consequence of
      ownership of the Lock-Up Securities, whether any such hedging, swap, loan or transaction is to be settled by delivery of Common Stock or other securities, in cash or otherwise, or (iii) publicly disclose the intention to do any of the foregoing
      described in clauses (i) and (ii) above.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer the Lock-Up Securities without the prior written consent of the Representatives as described below,
      provided that (1) in the case of clauses (i), (ii), (iii), (v), (vi), (vii) and (viii) below, the Representatives receive a signed lock-up agreement in the form of this lock-up agreement for the balance of the Lock-Up Period from each donee, devisee,
      trustee, distributee, or transferee, as the case may be, (2) in the case of clauses (i), (ii), (v), (vii) and (viii) below, any such transfer shall not involve a disposition for value, (3)<font style="color: #000000;"> in the case of clauses (v),
        (vi) and (viii) below, such transfers are not required to be reported during the Lock-Up Period with the Commission on Form 4 or Form 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), (4) in
        the case of clause (i), (ii), (iii), (iv), (ix), (xi) and (xii) below, any such required filing shall clearly indicate in the footnotes thereto that the filing relates to circumstances described in such a clause, and (5) the undersigned does not
        otherwise voluntarily effect any public filing or report regarding such transfers:</font></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf8499f00c29640509cd1839f598a9248">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>as a <font style="font-style: italic;">bona fide</font> gift or gifts, including, without limitation, to a charitable organization or educational institution, or for <font style="font-style: italic;">bona fide </font>estate planning
              purposes;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8e703f1be551467b93d45cdaf752e1bf">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>by will, testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the undersigned (for purposes of this lock-up agreement, &#8220;immediate family&#8221; of the undersigned
              shall mean any relationship by blood, marriage, domestic partnership or adoption, not more remote than first cousin of the undersigned);</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4eab377f7dd94e53aa00cf2d744dbd68">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(iii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z871cff9d37c547ac903f65e31149170e">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(iv)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>pursuant to an order of a court or regulatory agency having jurisdiction over the undersigned;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2fda6291011f440488fea3c0c44fad6f">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(v)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to any corporation, partnership, limited liability company or other entity of which the undersigned or the immediate family of the undersigned are the legal and beneficial owner of all of the outstanding equity securities or similar
              interests;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z856237ca328a4ecf905b77f819aeeda4">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(vi)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (v) above;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcff32b3b0e42499c893568365442fdd0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(vii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to any immediate family member or any trust, partnership, limited liability company or other entity for the direct or indirect benefit of the undersigned or one or more immediate family members of the undersigned, or if the undersigned is
              a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1e195f95adbe4ecabadfba6d13eb465b">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(viii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as
              defined in Rule 405 promulgated under the Securities Act) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the
              undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B) as part of a distribution to
              limited partners, limited liability company members or stockholders of the undersigned or holders of similar equity interests in the undersigned;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z81b8a399e5c846b7862ce5940978665c">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(ix)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to the Company upon the undersigned&#8217;s death, disability or termination of employment or other service relationship with the Company; <font style="font-style: italic;">provided that</font> such shares of Common Stock were issued to the
              undersigned pursuant to an agreement or equity award granted pursuant to an employee benefit plan, option, warrant or other right disclosed in the prospectus for the Public Offering;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf88d8f7ecfbb41e79d0e823ace7b5c8c">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(x)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>pursuant to a bona fide third-party tender offer, or in connection with a merger, consolidation or other similar transaction, that is approved by the Board of Directors of the Company, made to all holders of the Company&#8217;s capital stock
              involving a change of control of the Company (including, without limitation, entering into any lock-up, voting or similar agreement pursuant to which the undersigned may agree to transfer, sell, tender or otherwise dispose of Lock-Up
              Securities in connection with such transaction, or vote any Common Stock or other securities in favor of any such transaction); <font style="font-style: italic;">provided that</font>, in the event that such tender offer, merger,
              consolidation or other transaction is not completed, the undersigned&#8217;s Lock-Up Securities shall remain subject to the restrictions set forth in this lock-up agreement; <font style="font-style: italic;">provided further that</font> any shares
              of Common Stock not transferred, sold or otherwise disposed of in such third-party tender offer, merger, consolidation, or other similar transaction shall remain subject to the restrictions set forth in this lock-up agreement (for purposes
              hereof, &#8220;change of control&#8221; shall mean the transfer, sale or other disposition (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of
              affiliated persons, of shares of capital stock of the Company if, after such transaction or transactions, such person or group of affiliated persons would hold more than 50% of the outstanding voting securities of the Company (or the
              surviving entity));</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0c9bb105bfc14440b0d79b22b281da66">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(xi)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to the Company pursuant to the vesting or settlement of restricted stock units or performance stock units or the exercise of options or other rights to purchase the shares of Common Stock (including, in each case, by way of &#8220;net&#8221; or
              &#8220;cashless&#8221; exercise), including any transfer, sale or other disposition to the Company for the payment of exercise price, tax withholdings or remittance payments due as a result of the vesting, settlement or exercise of such restricted stock
              units, performance stock units, options or rights; <font style="font-style: italic;">provided that</font>, in each case, any such restricted stock units, performance stock units and options to purchase shares of Common Stock were granted
              under an equity incentive plan or other equity award plan that is described in the Prospectus and provided further that, in each case, any such shares of Common Stock received by the undersigned upon such vesting, settlement or exercise that
              are not so transferred, sold or otherwise disposed shall be subject to the restrictions set forth in this lock-up agreement; or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z02ee7f72862f4e41a9da008b9a6759db">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(xii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>pursuant to a 10b5-1 trading plan that complies with Rule 10b5- 1 under the Exchange Act (&#8220;10b5-1 Trading Plan&#8221;) that has been entered into by the undersigned prior to the date of this lock-up agreement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000;">Notwithstanding anything herein to the contrary, nothing in this lock-up agreement shall prevent the undersigned from establishing a 10b5-l Trading Plan or from amending an existing
      10b5-l Trading Plan so long as there are no sales of Lock-Up Securities under such plan during the Lock-Up Period; and provided that, the establishment or amendment of a 10b5-1 Trading Plan shall only be permitted if any public announcement or filing
      under the Exchange Act, if required or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment or amendment of such plan, shall include a statement to the effect that no transfer of Lock-Up Securities may be
      made under such plan during the Lock-Up Period.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000;">Furthermore, the undersigned may sell shares of Common Stock of the Company purchased by the undersigned on the open market following the Public Offering if and only if (i) such sales
      are not required to be reported in any public report or filing with the Securities and Exchange Commission or otherwise, and (ii) the undersigned does not otherwise voluntarily effect any public filing or report regarding such sales.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">The undersigned acknowledges and agrees that the underwriters have neither provided any recommendation or investment advice nor solicited any action from the undersigned
        with respect to the Public Offering of the Common Stock and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. </font>The undersigned further acknowledges and agrees
      that, although the underwriters may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to the undersigned in connection with the Public Offering, the underwriters are not making a recommendation to the
      undersigned to enter into this lock-up agreement and nothing set forth in such disclosures is intended to suggest that any underwriter is making such a recommendation.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">The undersigned hereby represents and warrants that the undersigned has full power, capacity and authority to enter into this lock-up agreement. </font>The undersigned
      understands that the Company and the underwriters are relying upon the lock-up agreement in proceeding toward the consummation of the Public Offering. The undersigned further understands that this lock-up agreement is irrevocable and shall be binding
      upon the undersigned&#8217;s heirs, legal representatives, successors and assigns.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000;">The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#8217;s transfer agent and registrar against the transfer of the Lock-Up Securities
      except in compliance with the foregoing restrictions.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">Notwithstanding anything to the contrary contained herein, this lock-up agreement will automatically terminate and the undersigned will be released from all of their or
        its obligations hereunder upon the earliest to occur, if any, of the following: (i) prior to the execution of the Underwriting Agreement, the Company advises </font>the Representatives<font style="color: #000000;"> in writing that it has
        determined not to proceed with the Public Offering, (ii) the Underwriting Agreement is executed but is terminated (other than with respect to the provisions thereof which survive termination) prior to payment for and delivery of the Common Stock to
        be sold thereunder or (iii) August 31, 2025 in the event that the Public Offering shall not have occurred on or before such date (provided that the Company may, by written notice to the undersigned prior to such date, extend such date for a period
        of up to an additional three months).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">This lock-up agreement shall be governed by and construed in accordance with the laws of the State of New York.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">This lock-up agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same lock-up
      agreement. Electronic signatures complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. &#167;&#167; 301-309), as amended from time to time, or other applicable law will be deemed original signatures for purposes of this lock-up
      agreement.&#160; Transmission by telecopy, electronic mail or other transmission method of an executed counterpart of this lock-up agreement will constitute due and sufficient delivery of such counterpart.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2f1ea0d4865d436ead5a865e2b8576db">

        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">Very truly yours,</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>[NAME OF OFFICER/ DIRECTOR]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>Name:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>Title:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>If not signing in an individual capacity:</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>Name of Authorized Signatory (Print)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div>Title of Authorized Signatory (Print)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="font-style: italic;">(Indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity.)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div><br>
      </div>
      <div style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">A-5</font></div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ny20052979x3_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.7.1.5324
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 5.1</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 61.55%; vertical-align: bottom; font-family: Arial,Helvetica,'sans-serif';">&#160;<img width="237" border="0" height="16" src="ny20052979x3_ex5-1img01.jpg"> </td>
              <td style="width: 38.45%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';" colspan="2">
                <div style="font-size: 8pt;">1271 Avenue of the Americas</div>
                <div style="font-size: 8pt;">New York, New York&#160; 10020-1401</div>
                <div style="font-size: 8pt;">Tel: +1.212.906.1200&#160; Fax: +1.212.751.4864</div>
                <div style="font-size: 8pt;">www.lw.com</div>
              </td>
            </tr>
            <tr>
              <td style="width: 61.55%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';">&#160;</td>
              <td style="width: 13.48%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';">&#160;</td>
              <td style="width: 24.97%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';">&#160;</td>
            </tr>
            <tr>
              <td style="width: 61.55%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';">&#160;</td>
              <td style="width: 38.45%; vertical-align: top;" colspan="2">
                <div style="font-family: Arial,Helvetica,'sans-serif'; font-size: 8pt;">FIRM / AFFILIATE OFFICES</div>
              </td>
            </tr>
            <tr>
              <td style="width: 61.55%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';">&#160;</td>
              <td style="width: 13.48%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';">
                <div style="font-size: 8pt;">Austin</div>
                <div style="font-size: 8pt;">Beijing</div>
                <div style="font-size: 8pt;">Boston</div>
                <div style="font-size: 8pt;">Brussels</div>
                <div style="font-size: 8pt;">Chicago</div>
                <div style="font-size: 8pt;">Dubai</div>
                <div style="font-size: 8pt;">D&#252;sseldorf</div>
                <div style="font-size: 8pt;">Frankfurt</div>
                <div style="font-size: 8pt;">Hamburg</div>
                <div style="font-size: 8pt;">Hong Kong</div>
                <div style="font-size: 8pt;">Houston</div>
                <div style="font-size: 8pt;">London</div>
                <div style="font-size: 8pt;">Los Angeles</div>
                <div style="font-size: 8pt;">Madrid</div>
              </td>
              <td style="width: 24.97%; vertical-align: top; font-family: Arial,Helvetica,'sans-serif';">
                <div style="font-size: 8pt;">Milan</div>
                <div style="font-size: 8pt;">Munich</div>
                <div style="font-size: 8pt;">New York</div>
                <div style="font-size: 8pt;">Orange County</div>
                <div style="font-size: 8pt;">Paris</div>
                <div style="font-size: 8pt;">Riyadh</div>
                <div style="font-size: 8pt;">San Diego</div>
                <div style="font-size: 8pt;">San Francisco</div>
                <div style="font-size: 8pt;">Seoul</div>
                <div style="font-size: 8pt;">Silicon Valley</div>
                <div style="font-size: 8pt;">Singapore</div>
                <div style="font-size: 8pt;">Tel Aviv</div>
                <div style="font-size: 8pt;">Tokyo</div>
                <div style="font-size: 8pt;">Washington, D.C.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">August 14, 2025</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">SPX Technologies, Inc.</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6325 Ardrey Kell Road, Suite 400</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Charlotte, North Carolina 28277</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> Re:&#160; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Registration Statement No. 333-289489</u><u>; 3,058,511</u><u>
              shares of Common Stock, par value $0.01 per share</u></font> </div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">To the addressee set forth above:</div>
      <div><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> We have acted as special counsel to SPX Technologies, Inc., a Delaware corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Company</font>&#8221;), in connection with the issuance of up to 3,058,511 shares (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Shares</font>&#8221;) of common stock, par value $0.01 per share (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Common Stock</font>&#8221;). The Shares
          are included in a registration statement on Form S&#8211;3 under the Securities Act of 1933, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Act</font>&#8221;), filed with
          the Securities and Exchange Commission (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Commission</font>&#8221;) on August 11, 2025 (Registration No. 333&#8211;289489) (as so filed and
          as amended, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Registration Statement</font>&#8221;), including a base prospectus dated August 11, 2025 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Base Prospectus</font>&#8221;), a preliminary prospectus supplement dated August 11, 2025 filed with the Commission pursuant to Rule 424(b) under the Act
          (together with the Base Prospectus, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Preliminary Prospectus</font>&#8221;), and a prospectus supplement dated August 12, 2025 filed
          with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Prospectus</font>&#8221;).&#160; The
          shares are being sold pursuant to an underwriting agreement, dated August 12, 2025, by and among the Company and, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters
          named therein (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Underwriting Agreement</font>&#8221;). This opinion is being furnished in connection with the requirements of Item
          601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, the Preliminary Prospectus or related Prospectus, other than as expressly stated herein with
          respect to the issue of the Shares. </div>
      <div><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this
        letter.&#160; With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters.&#160; We are opining herein as to General
        Corporation Law of the State of Delaware, and we express no opinion with respect to any other laws.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div><br>
        </div>
        <div style="font-size: 8pt; font-weight: bold;">August 14, 2025</div>
        <div style="font-size: 8pt; font-weight: bold;">Page 2</div>
        <div>&#160;</div>
        <div><img width="161" height="10" src="ny20052979x3_ex5-1img01.jpg"></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall
        have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated
        by the Underwriting Agreement, the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, and the Shares will be fully paid and nonassessable.&#160; In
        rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the General Corporation Law of the State of Delaware.</div>
      <div><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to
        rely upon it pursuant to the applicable provisions of the Act.&#160; We consent to your filing this opinion as an exhibit to the Company&#8217;s Current Report on Form 8-K filed with the Commission on August 14, 2025 and to the reference to our firm in the
        Prospectus under the heading &#8220;Legal Matters.&#8221;&#160; In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z7d5de18261b7491faa1f526777a26f13" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Sincerely,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/ Latham &amp; Watkins LLP</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>spxc-20250812.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.7.1.5324 Broadridge-->
<xs:schema targetNamespace="http://spx.com/20250812" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:spxc="http://spx.com/20250812" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="spxc-20250812_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="spxc-20250812_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://spx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>spxc-20250812_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.7.1.5324 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>spxc-20250812_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.7.1.5324 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://spx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="spxc-20250812.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://spx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ny20052979x3_ex5-1img01.jpg
<TEXT>
begin 644 ny20052979x3_ex5-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  = :P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[X_X-1_\
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MC6OQ_P#^#7S_ ),$^+W_ &>!X^_]4O\ L_U^P'_!0K_DP3]N+_LS_P#:7_\
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M;_#WQG_X**_\%Y/VJOC+\,/@W^T%XP_9_P#V0_#7_"3SWFDV]GXI\">$]$^
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M (31['XZ^)='U?\ X036/&<_BWPY_;GA/7OL&I6LHTS^R[J^?4H/Z$*_$_\
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M7?\ \*M_YI;_ ,*U_P"$8_X5K_PL7_JHOC_^VO[:_P"$_P#^H3_9W]D_\O\
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MR]_PGO\ PK'_ (6=_P (+_Q7/_"+?\)I_8?_  A?Q)\'?$/_ )%G_A(_"?\
M:7]I?\(G_9'_ ",&G_8_[0_M#_2OLOV*Y]K(<'G>#X1Q&5X[!\V88+#YC@L#
M3^L86V.HJE-X%JK3J3I8=3]HL+'V\HSIJDJE9)/F?YAXM\3^%O$GTB\DX]X4
MXD]EP?Q-G7!?$_%6,_L7/5+A/,Y8["4^+*=3 XO!87'YQ5POU.KGU665TJV'
MQ=3,)X/+ZDI4_94_PW_X-:/A?H&D_LQ?M+?&FVO-8?Q3X_\ CQI/POUFPGN+
M)M MM ^$'P^T/Q9X:O-,M8]/CU&'6+[4?CAXKAURXNM5O;*YLM/\/1V&GZ9/
M::E<ZM^)^@?'CQS_ ,$8_P!HK_@J5^RGI*_$BVT[XA_#?QI\)/A VF>)_!MG
MXRTK7]6U6UO?V9?C[XA^)OA6TAU7P]K'@_X"?$SQ=X_@L/ MOI-[J?CGQ!H?
MAW7O#W@[4;9-=^'W]I'_  3C_84\)_\ !/#]FC2_V?\ PYXG_P"$]UB?QAXL
M\?>/OB)_8NI>%O\ A.?%GB.[@L;/5O\ A$;[Q?XVM?#/]C^!=#\%^"_L.C:R
M--U#_A%O^$CELX-8UO5GF_/?_@I?_P $*] _X*$_M%67[0FC?'W1_@%J,GPW
M\,^"?%>C:9\!K+QK>^-M?\,ZKXDDMO'?B'Q+:_%#P!/J&L-X6U/PUX*@74M,
MU*]L] \$Z'8QZQ)IUM8:;IGSV.X6SJCPMPW3RJBJ>?Y*JO[JE7P\%"&:4:RS
M&'MJM2%"513J4W.U65&;C5C%5H2BS]DX4\??"[,_'[QOQGB#F<\5X/\ B;/+
M6L;CLHSG$/%XG@/,<KJ<%XF679=@L5FM'!2PN"QD<*JN7T<PP\*N!J5WEN)I
M5Z:V/^#=W]F;_A17_!/W1/B3KFB_V=XZ_:<\8:W\5]0EU;P+_P (IXLL_ &G
M./!?POT"\UF\DDUCQAX/OM'T'4_BYX!U2>/3M%73?C#?7'A[3IK74;CQ'XC_
M !__ .#=GPAX_P#@-_P4Z_;%_9J\1^*/M'_"N_@_\6_"'C[2?"^MZU-X \2>
M/_@S^T%\-/ -GXHMK&^MM'_MC^Q_[8\:6WA#6]9T&QUK3]%\5:W#%;:7_;FK
M6<O]F'P\\!>$_A5X \#_  O\ Z3_ &#X%^&_@_PSX!\%Z']NU+5/[&\)^#]%
MLO#WAS2?[3UF\U'6-1_L[1].L[/[=JVH7VI7?D_:+Z\NKJ26=_Q/^!W_  1,
M_P"%,_\ !2_6O^"B?_#3/_"2?VQ\8/VA?BO_ ,*?_P"%,_V/]G_X7SI/Q+TO
M^P/^%@?\+6U3SO\ A%?^%B>?_:G_  A$7]N?V/Y7]G:/_:'F6/JXKAO%X27
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MC\1CL!3J9=0K4<'3K2KSK?F__P $_OV4?C]^Q;HNM_!?QIX]^#_QS^%NJ_\
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MK2GEE3.*V.HXW.ZBPV%CA,-6K3_$_P#X.@_^3!/A#_V>!X!_]4O^T!7[ ?\
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*XP:II^SA",?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 12,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-06948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SPX TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000088205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-3567996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6325 Ardrey Kell Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Charlotte<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">474-3700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SPXC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20052979x3_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ny20052979x3_8k.htm">ny20052979x3_8k.htm</File>
    <File>spxc-20250812.xsd</File>
    <File>spxc-20250812_lab.xml</File>
    <File>spxc-20250812_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20052979x3_8k.htm": {
   "nsprefix": "spxc",
   "nsuri": "http://spx.com/20250812",
   "dts": {
    "inline": {
     "local": [
      "ny20052979x3_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "spxc-20250812.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "spxc-20250812_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "spxc-20250812_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://spx.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250812to20250812",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20052979x3_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250812to20250812",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20052979x3_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://spx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-25-031186-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-031186-xbrl.zip
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MJZ5D"R?W[__V?']_]R6HDGDVNZ6?]EYNI_#!V;BHIG52-##\2UA^,FQO"M@
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MHPR7R^T4Z;.:%*<[+_N'Z!YMI&;I*^ZNE27X1/HE'"GN/RL>W!'6/N-%-2O
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MUQD\WG !<)AG=;V N>A7?@'M] :FD_PJD0]_2C FFV'$!#0C3)=/^#:8IO"
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MHVV0DR$(0RW&12OO^^K)OMP.O]]&OD5U"N-ZB(W$,P ;L;[(_)'2'JV/<2J
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MO ?T!CR4W)RR\NL0O%Q$82.SK#T(!EOB=X9YCD]F*7-9"43%N02*W\]BYK#
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M0)\[75F(H\MQGX$<78<U0O]+MXHIAFP\VND,ZEXOT6H)Z=1JB477?>5""*O
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MZ>Z2K^9\<(J_P[5;#!D:\%->C/I?L)>0'SI;2%T #!+PX)Z1-R]<DM@N@,D
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M;>+>=!*,>G4:32U4Q$'2T:OJ5A90L7.QA*//ESI%W':D/ I1 =G):SD4KG>
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M,%T8[] HW3J1%70SG</A^D1\19#D6]I@]T]^<^RQ5:^5%F9U2(3OK*;'5W&
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M#MH)]GRTW;4YY B$@1/3:$&BO:!*LDO.K63) &G .?MH31ZO7+1HGO+R AF
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M T8(JS?[RW?[;GWBS[!?E#WY3Z)GJ+#\!66V3D.EP&<F>"?\:*<1FU15WO"
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MQ,NLV.(1V*&19UE1S)F5,+1'+(M%T:/R4MC[<&/^RJ[ _/AP ASC/:OY 2?
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MQH.C 2,G_@Z0E+#MGM!4 [:IP()(DG<ZY*RJ,OH*82$D457B*$6!N28] E[
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M1;Z#O*N/6XTX5K?O<=JK^C/PK6G>;,4CV4559"IBB9,W6LK?D(KM&JH,3@[
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M7\DP=G[A'!"%*R$!5/*BS66I<5OT1-1]SHP!P#UN4*F\4M'*TKD8S&1+X_M
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M_B.3P&H7@LYLT%T$<HXPPNO;D#M>EZ"A4SI#\_MH$%P/B)IOX1%ZB +Q*2S
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MJB!*V*\-RG(FJ",=AF9Y!B5N]'?B:POQ>#P.[6H3JHG($6K"I((,X79\HAI
M.W@45HLN-,%D,TYB%,SY2Z@7[ Z;0"5\M<JQW.]#+X=FV6 N_"CVA[%#ZG+8
M!*90SBS(K6P(2:$.Q3=+%4"7!P"F0"!C7$&E:]%.U9-Y3EC*ZQD]9S(Z<:?P
MC%-@<SPQA%-/DBRG)H%V;B%PJN?TJ?ONE'_F @?:H0L1G.(C1V*60PV1N@ZM
ML\>UL*.  NVP[-2 )N$Y%HKH7:]+*/QGVZ)PUG5;&H+I_]V/X?FF=P#,X/OS
MPT[S62.W'!6FT=^SY(XIHE8/^L!%9O/M 9),O:,1C:9337!*&+%U%.E[((J
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M>&ULU5M=;^(X%'U?:?]#EGV&%)C.#%69$<M,1VB9%A56^_&R,HD!:Y,8.:'
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M7Q!?-C]$Q _QY>Q/_P-02P$"% ,4    " "8>PY;[Z6B]4\5   8@   $P
M            @ $     ;GDR,# U,CDW.7@S7SAK+FAT;5!+ 0(4 Q0    (
M )A[#EN0.#64X98  (4H P 6              "  8 5  !N>3(P,#4R.3<Y
M>#-?97@Q+3$N:'1M4$L! A0#%     @ F'L.6\]VRG[,"P  ,#8  !8
M         ( !E:P  &YY,C P-3(Y-SEX,U]E>#4M,2YH=&U02P$"% ,4
M" "8>PY;47^@#3X#   J#P  $0              @ &5N   <W!X8RTR,#(U
M,#@Q,BYX<V102P$"% ,4    " "8>PY;>\\K"'L(   P5@  %0
M    @ $"O   <W!X8RTR,#(U,#@Q,E]L86(N>&UL4$L! A0#%     @ F'L.
M6U19GI;8!0  YSX  !4              ( !L,0  '-P>&,M,C R-3 X,3)?
=<')E+GAM;%!+!08     !@ & (X!  "[R@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ny20052979x3_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="spxc-20250812.xsd" xlink:type="simple"/>
    <context id="c20250812to20250812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000088205</identifier>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250812to20250812"
      id="Fact_833ca6278d524b5992cbb3957dd215fb">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20250812to20250812"
      id="Fact_20a1f1e0b0ff4784871a52432c5cec63">0000088205</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20250812to20250812"
      id="Fact_6a981d5b34f34ddc9500cc8d5f4a4023">NYSE</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20250812to20250812"
      id="Fact_282092fe9e2a4a868bc2af5490ce424c">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250812to20250812"
      id="Fact_e3e9090faae643a0aaa56edfd8e1ea75">2025-08-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250812to20250812"
      id="Fact_d2e7220e9c9a47839816231bea7e3456">SPX TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250812to20250812"
      id="Fact_9d150545495c415fb13fddcb30491cba">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250812to20250812"
      id="Fact_f1c82bac3ed240cebcfc4ecaec16a9d0">001-06948</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250812to20250812"
      id="Fact_5dcb4cd1a1af43048da3d2b8036eb214">88-3567996</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250812to20250812"
      id="Fact_ee9ba791d9d54ca8844d2fc60f8e5a3c">6325 Ardrey Kell Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20250812to20250812"
      id="Fact_d32488ebb92f41589b76a75e54dc8dd9">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20250812to20250812"
      id="Fact_b240bfd8717b4f07bd8a289c0fa1319a">Charlotte</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250812to20250812"
      id="Fact_ded8fd4ad9cd4ad2b2469432ac6be95a">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250812to20250812"
      id="Fact_28e51f5699954e51bb51ef7d24a8ca95">28277</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250812to20250812"
      id="Fact_725411ff89a24079a7c4c1cf716d6fdc">980</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250812to20250812"
      id="Fact_a4d399c20f1b4664bc908f9751afc8fa">474-3700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20250812to20250812"
      id="Fact_cf531161edea453090f2091dc21e4b83">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250812to20250812"
      id="Fact_77b672ce78c8493898ab035299a96211">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250812to20250812"
      id="Fact_0224889554bb4af79ec589a379aee524">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250812to20250812"
      id="Fact_6469781dce564dd0802c2b5c0985f8f4">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250812to20250812"
      id="Fact_0c0e70c5123647adbdba1c440b568346">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250812to20250812"
      id="Fact_46297e4de46d499090d35daa2245d7f3">SPXC</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250812to20250812"
      id="Fact_cfa537401b6f4c4fb1d0dc20759bdef6">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
